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Approximately 2% of all pregnancies in the Netherlands are multiple gestations, 
of which 0.3% of all pregnancies are monochorionic (MC) twin pregnancies.1,2 MC 
twins have a perinatal mortality twice as high as dichorionic twins, and four times 
higher than singletons.3,4 The increased risk for adverse pregnancy outcome derives 
mainly from the communicating vessels on the placental surface, that connect the 
fetal blood circulations to each other. These vascular anastomoses are present in 
nearly all monochorionic twin placentas.5 Three types of anastomoses are identified 
(Figure 2). The arterio-venous (AV) anastomosis is most frequently present, which has 
unidirectional flow from one fetus to the other. The arterio-arterial (AA) anastomosis 
and veno-venous (VV) anastomosis have the possibility of bidirectional flow, and the 
direction of blood flow is dependent on the (blood) pressure gradient.6,7
Fetal cardio-placental circulation 
The fetal circulation differs from the postnatal circulation, mainly because the lungs 
are not yet in use. For oxygenation, the fetus is dependant of a organ outside the 
body; the placenta. Once the blood is oxygenated, it is transported to the fetus via 
the umbilical vein and ductus venosus to enter the right atrium of the fetal heart. To 
bypass the pulmonary circulation of the fetal body, most of the oxygenated blood that 
enters the heart passes the foramen ovale or the ductus venosus directly into the left 
ventricle or the aorta. From there, it is transported the fetal body to oxygenate the 
end organs.
Because the fetal blood circulation contains a fetal and a placental part, abnormal 
placental resistance consequently influences fetal blood circulation and well-being.8 In 
MC twins, a third component is added to the cardio-placental circulation: the shared 
blood circulation of the co-twin. The unique placental angioarchitecture with different 
types and sizes of anastomoses from one twin to the other, carry extraordinary 
hemodynamic challenges for the fetal heart, and causes specific complications in MC 
twins.
◀Figure 1. Possible complications of monochorionic pregnancies  
Equal placental sharing and a balanced exchange of blood through the communicating vessels 
(anastomoses) are required for an uncomplicated course of the pregnancy (above). In case of 
unbalanced exchange of blood through the anastomosis, twin-to-twin transfusion syndrome 
(TTTS, middle) occurs. In case of unequal placental sharing, selective intrauterine growth 
restriction (sIUGR, below) takes place
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▲Figure 2. Picture of a monochorionic twin placenta injected with coloured dye. This 
placenta illustrates different types of anastomosis. AA = arterio-arterial anastomosis, AV = 
arterio-venous anastomosis
Complications in MC pregnancies
Common placenta related complications of MC pregnancies are twin-to-twin 
transfusion syndrome (TTTS) and selective intrauterine growth restriction (sIUGR). 
More seldom, spontaneous twin anaemia polycythemia sequence (TAPS), twin 
reversed arterial perfusion (TRAP) and conjoined twins are seen. This thesis focusses 
mainly on the hemodynamic challenges in  TTTS and sIUGR.
Twin-to-twin transfusion syndrome
In about 10-15% of MC pregnancies, imbalanced blood flow over one or more AV-
anastomosis leads to twin-to-twin transfusion syndrome. The staging of TTTS is 
currently based on ultrasonographic features, described by Quintero et al.7 The overall 
mortality and morbidity rate is up to 90% if left untreated.9 The current treatment is 
laser coagulation of the placental vascular anastomoses. The results of laser surgery 




Selective intrauterine growth restriction 
A disproportionate distribution of placental mass between the twins is the cause of 
sIUGR (Figure 2). sIUGR affects approximately 10% of MC twins, severe cases of sIUGR 
can result in spontaneous fetal demise of the smallest twin with subsequent hypoxia 
with cerebral damage or even secondary fetal demise of the larger twin.12-14 Severity 
of disease is classified in the Gratacos staging system, according to umbilical artery 
Doppler flow in the smaller twin (Figure 6). Currently there is no treatment for sIUGR. 
Cardiovascular adaptation in complicated MC 
twins
Prevalence of cardiac compromise
The current Quintero staging system only includes indirect signs of cardiac dysfunction, 
namely absent end-diastolic flow in the umbilical artery (Figure 3), abnormal a-wave 
in ductus venosus (Figure 4) and hydrops.13 Up to 70% of TTTS recipients, however 
show direct signs of cardiac compromise at the time of diagnosis.15-17 Even in early 
Quintero stages, myocardial hypertrophy, atrioventricular valve regurgitation and 
elevated myocardial performance index (Figure 5) is observed.15,16,18,19 In studies that 
were performed in advanced stages of TTTS, more severe cardiomyopathy was found, 
such as prominent cardiomegaly (Figure 6) and massive atrioventricular regurgitation 
(Figure 7). Another finding is the absence of forward flow across the pulmonary 
valve, in some cases with excusive reversed direction of flow in the ductus arteriosus 
(Figure 8), reflecting right ventricular outflow tract obstruction (RVOTO). This can be 
attributed to either anatomical changes of the valve (anatomical stenosis or atresia), 
either the lack of pressure in the right ventricle during systole which prevents forward 
flow across the valve (functional atresia). RVOTO is leading to hydrops in 10-15% of 
cases.17-20 RVOTO may be progressive during pregnancy and may require urgent 
pulmonary balloon valvuloplasty or surgery after birth.20 The prevalence of severe 
postnatal RVOTO varies between 3 to 7% of all surviving TTTS recipients, which is 




Several factors leading to right ventricular outflow tract obstruction in the recipient of 
TTTS have been suggested. An increase in cardiac preload leads to right ventricular 
hypertrophy and impaired cardiac function. Severe myocardial hypertrophy and 
cardiac dysfunction can cause decreased or absent flow across the pulmonary valve 
(functional atresia), which might lead to underdevelopment of the valve. 15,16,19,21,23,24 
Besides that, endothelial damage caused by shear stress might eventually result in 
valve dysplasia, causing pulmonary valve stenosis. At the same time, the donor has 
inadequate placental return of blood volume which activates vasoactive mediators 
such as endothelin-1, renin, and angiotensin II.25-28  Those vasoactive mediators are 
transfused to the recipients circulation, in which they have an adverse effect due to 
vasoconstriction in an already overloaded circulation.
Myocardial hypertrophy and the development of RVOTO is also described in the 
larger twin in MC pregnancies complicated with sIUGR.29-31 It is suggested that cardiac 
abnormalities in the larger twin are caused by a hyperdynamic state due to the 
disproportion of the placental territory, and amplified by hemodynamic imbalances 
related to the presence of a large AA anastomosis and possible exchange of vasoactive 
mediators from the donor.32
▲Figure 3. Different types of end diastolic flows over the umbilical artery; positive flow (Gratacos 
stage I, left), continuous absent flow (Gratacos stage II, middle) and intermittent positive, absent 




▲Figure 4. Normal fl ow (left) and reversed A-wave (right) in the ductus venosus
.
 ◀Figure 5. Myocardial Performance Index  
 (MPI = [IVCT+IVRT]/ET) using conventional  
 pulsed wave Doppler technique
▲Figure 6. Normal cardiac size (right), cardiomegaly in a recipient (middle) and severe 




▲Figure 7. Normal Doppler fl ow over the tricuspid valve (right and severe tricuspid insuffi  ciency 
with holosystolic regurgitation
▲Figure 8. Normal V-sign (right) with antegrade fl ow over the ductus arteriosus, and right 




Echocardiographic assessment in MC twins
The challenge of fetal echocardiography
Assessment of cardiac function is more challenging in the fetus than in adults. Firstly, 
the cardio-placental circulation is different than the cardio-respiratory circulation, 
and the fetal heart is smaller with an higher heart rate compared to postnatal life. 
Secondary, fetal position and fetal movements influences cardiac imaging highly. 
Finally, maternal factors such as high body mass index or maternal (breathing) 
movements may affect optimal scanning circumstances, and accompanying 
fetal electrocardiogram currently unable to establish. In TTTS pregnancies, fetal 
echocardiography is even more challenging due to polyhydramnios/anhydramnios, 
and often abundant fetal movements of the recipient.
Echocardiographic assessment techniques in monochorionic 
twins
In complicated MC twins, conventional pulsed-wave Doppler (PW) techniques are 
widely used to determine disease severity. PW-Doppler imaging of the umbilical artery 
and ductus venosus, as indirect signs of cardiac dysfunction, are included in staging 
of TTTS and sIUGR.13,35 PW-Doppler is used as well to detect direct signs of cardiac 
deterioration such as atrioventricular valve regurgitation and increased myocardial 
performance index. 
New ultrasonographic techniques such as speckle tracking technique, strain rate 
and color-coded Tissue Doppler Imaging are explored in fetal echocardiography.34 
Since the last decades these techniques have been used in adult echocardiography 
increasingly, but the clinical use in fetal echocardiography is still under investigation.36,37 
In TTTS, several studies have been done to evaluate speckle tracking and strain rate 
in recipient twins.38-41 Right ventricular failure could be identified in recipients in all 
studies, but the feasibility was only 61%,40 which prevents from implementation in 
daily clinical use. 
In conclusion, fetuses in complicated monochorionic twins suffer serious hemodynamic 
challenges due to imbalanced blood flow through the communicating vessels in 
their shared placenta. They are at increased risk of developing cardiac dysfunction, 
followed by acquired heart diseases or eventually fetal demise. Fetoscopic laser 
 Chapter I
18
coagulation, which is the curative treatment for TTTS, reduces fetal demise drastically 
and is associated with a significant improvement of cardiac function. However, it does 
not prevent fetal demise or development of subsequent cardiac defects in all cases.42 
Echocardiographic assessment in complicated twin pregnancies  is challenging, 
and new modalities to detect early cardiac dysfunction and predict fetal demise or 
development of severe RVOTO are still under investigation.
Aim and outline of this thesis
The general aim of the studies presented in this thesis was to gain more knowledge 
about hemodynamic adaptation of the fetal heart in complicated monochorionic 
twin pregnancies, in order to understand more of the pathways of abnormal cardiac 
development and fetal demise under these circumstances, which eventually could lead 
to better future care. In part one, we aimed to investigate possible risk factors for fetal 
demise after laser therapy for TTTS. Besides that, we investigated the consequence 
of proximate cord insertion on the fetal condition in otherwise uncomplicated MC 
pregnancies. In part two, we aimed to investigate the spectrum of RVOTO and aim to 
develop an prediction model for development of postnatal RVOTO. Lastly, we aimed 
to develop a new echocardiographic modality to identify fetal cardiac deterioriation. 
Chapter 1 provides a general introduction that led to this thesis.
Part one – fetal demise
In Chapter 2 we performed a systematic review and meta-analysis to compare 
preoperative ultrasonographic parameters between fetuses with and without fetal 
demise after laser surgery, in order to identify parameters predictive of demise.  In 
Chapter 3  we studied fetal demise in recipients as well as in donors after laser therapy 
for TTTS. We performed a retrospective cohort study, to determine independent 
factors associated with single fetal demise. Chapter 4 describes the phenomenon of 
abnormal flows in pregnancies with proximate cord insertions. We performed a case 
control study in which we compared the presence of abnormal flows in pregnancies 




Part two – cardiac compromise
Chapter 5 focusses on the hemodynamic adaptation of the right ventricle outflow 
tract in complicated monochorionic twin pregnancies. In this retrospective cohort 
prenatal ultrasonographic data of all neonates with postnatal RVOTO after TTTS 
were compared with those without postnatal RVOTO. We describe four additional 
cases with postnatal RVOTO that were not TTTS recipients. In Chapter 6 we perform 
a prospective longitudinal study to investigate the development and spectrum of 
RVOTO in TTTS recipients during pregnancy until the neonatal period. In Chapter 7 
we introduce a new ultrasonographic tool to detect cardiac deterioration, based on 
color-coded tissue Doppler imaging. We constructed reference ranges for cardiac 
time intervals in healthy singleton pregnancies and evaluated the applicability of this 
modality. We applied this technique to TTTS recipients before laser therapy, to test 
the diagnostic performance in fetuses with cardiac compromise.
In Chapter 8 we discuss the results of this thesis and we evaluate their implications 
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CHAPTER II
The value of echocardiography and 
Doppler in the prediction of fetal demise 
after laser coagulation for TTTS:  




Objective   
This study aimed to investigate the value of echocardiography and Doppler before 
fetoscopic laser coagulation for twin-twin transfusion syndrome (TTTS) in the 
prediction of intrauterine fetal demise (IUFD). 
Methods  
We performed a systematic review and meta-analysis to compare preoperative 
parameters between fetuses with and without demise after laser surgery. Eighteen 
studies were included. 
Results  
Recipient twins have an increased risk of demise in case of preoperative absent/
reversed flow (A/REDF) in the umbilical artery (odds ratio [OR] 2.76, 95% confidence 
interval [CI]: 1.78-4.28), absent or reversed a-wave in the ductus venosus (OR 2.32, 
95% CI: 1.70-3.16) or a middle cerebral artery peak systolic velocity >1.5MoM (OR 
7.59, 95% CI: 2.56-22.46). In donors, only A/REDF in the umbilical artery (OR 3.40, 95% 
CI: 2.68-4.32) and absent or reversed a-wave in the ductus venosus (OR 1.66, 95% 
CI:1.12-2.47) were associated with IUFD. No association was found between donor-
IUFD and preoperative myocardial performance index (MPI). Two studies found an 
association between abnormal MPI and recipient demise. 
Conclusion  
With this study we have identified a set of preoperative Doppler parameters predictive 
of fetal demise after laser surgery. More research is needed to assess the utility of 
preoperative echocardiographic parameters such as the MPI in predicting IUFD.




Twin-twin transfusion syndrome (TTTS) complicates approximately 10-15% of 
monochorionic twin pregnancies and results from unbalanced intertwin transfusion 
through placental vascular anastomoses which impacts cardiovascular loading 
conditions.1,2 If left untreated, the overall perinatal mortality can be as high as 90-
100%.3,4 Fetoscopic laser coagulation of placental anastomoses significantly improves 
the dual twin survival rate to 64%-70% and the survival rate of at least one survivor 
to 85%-92%.5,6 Survival after surgery is determined by a combination of post-laser 
intrauterine fetal demise (IUFD) and non-viable delivery. Compromised cardiac 
function is thought to contribute significantly to the mortality rates after TTTS.7 
Cardiac (functional) abnormalities, most commonly observed in recipients8-10 are, 
however, not taken into account in the disease severity classification by Quintero.11 
The diagnosis of TTTS is made by ultrasound and encompasses the presence of 
concurrent polyhydramnios in the recipient and oligohydramnios in the donor twin.12 
Since fetuses with cardiac compromise are more likely to die in utero, assessment 
of fetal cardiac function prior to laser surgery might help in staging disease severity. 
Several studies have focused on fetal circulation and cardiac involvement in TTTS and 
the prognostic value of these measurements. The objective of this systematic review 
and meta-analysis was to determine the capability to predict IUFD after fetoscopic 
laser coagulation with echocardiography and Doppler before surgery. 
Methods
Search strategy
This systematic review was performed using the PRISMA methodology.13 Relevant 
articles were identified using electronic databases (Pubmed, Embase, Web of Science 
and Cochrane). Publications from January 1990 to July 2018, written in English and 
containing the search terms related to twin-twin transfusion syndrome, fetoscopic 
laser coagulation, prediction of fetal demise and ultrasonography were included. The 
complete search string is available in Supplement 1. The final search was performed on 
10/01/2018. Two reviewers (MG and SE) screened titles and abstracts independently 
for relevance. If a title or abstract seemed relevant, full text was retrieved and assessed 
for inclusion. Selected articles were cross-referenced. Disagreement was resolved by 
consensus between the two reviewers. Studies were excluded from the analysis if no 
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ultrasound had been performed prior to laser surgery or IUFD was not an endpoint 
of the study. IUFD was defined as fetal demise at any time after laser surgery and 
before onset of labor.
Quality assessment
Study quality and risk of bias was assessed by the two reviewers using the Hayden 
bias rating tool,14 as suggested by the Cochrane Collaboration. With this tool the risk 
of bias was assessed in 6 domains (study participation, study attrition, prognostic 
factor measurement, outcome measurement, study confounding, and statistical 
analysis and reporting). Each of the 6 potential bias domains was rated as having 
high, moderate, or low risk of bias. Low methodological quality was not an exclusion 
criterion.
Data extraction
One reviewer (MG) extracted relevant information from the selected articles. The 
following data were extracted from the selected articles and tabulated: first author, 
year of publication, study design, country of origin, number of patients, type of 
fetoscopic laser surgery (selective laser photocoagulation of communicating vessels 
[SLPCV] or the Solomon technique5), operationalization of primary outcome and 
outcome measurement and the incidence of IUFD in cases and controls (2 x 2 tables). 
If possible, deaths attributable to pregnancy loss before 24 weeks gestation or 
termination of pregnancy were excluded from the analyses. 
Statistical analysis
Statistical analysis was performed using Review Manager 5.3 (Copenhagen: The Nordic 
Cochrane Center, The Cochrane Collaboration, 2014). Odds ratios (OR) and their 95% 
confidence intervals (CI) were used as effect sizes for meta-analysis of dichotomous 
data. Heterogeneity between studies was examined with the inconsistency square 
(I2) statistics, with between-study heterogeneity at I2 ≥ 50% and p ≥ 0.05.15 In case of 
heterogeneity, a random effects model was used.16 Otherwise, or in case of limited 
studies to reliably estimate between study variability, a fixed effect model was used. 
We performed meta-analyses and constructed forest plots to examine the effect of 
abnormal Doppler flow velocity waveforms (FVW) on IUFD with separate analyses for 
recipients and donors. Absent and reversed end diastolic flow (A/REDF) in the umbilical 
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artery (UA) were combined in one group. Likewise, absent or reversed a-wave in the 
ductus venosus (DV) were combined in one group. Parameters measured in the same 
twin were used for the analyses (i.e. umbilical artery Doppler in the recipient twin in 
relation to recipient IUFD).
Results
The search resulted in 473 articles, of which 18 were included in this study (Figure 
1). The study characteristics are summarized in Table 1. Quality assessment is 
summarized in Table 2. 
Overall IUFD 
Five studies report on fetal demise in the first 24h after surgery. An IUFD rate of 
12% for donors and 8% for recipients was reported.17-21 If the period is extended 
to the first week after laser surgery the mortality rates increase to 17% and 15% 
respectively.19,20,22 In studies including all fetal deaths before onset of labor 23% of 
donor twins and 17% of recipient
 
▲Figure 1. Flow chart demonstrating results of systematic review
twins died in utero.19,21,23-33 In the early years of fetoscopic laser coagulation (1998-
2008) these rates were 29% and 21%. These rates improved to 19% and 13% 




Three studies were excluded from the meta-analysis19,33,34 because abnormal Doppler 
FVWs were not analyzed in relation to IUFD19,33 or only time-interval variables of the DV 
FVW were analyzed.34 Since the number of included studies was too small for reliable 
assessment of between-study variance, a fixed effect model was used throughout.
We estimated the prevalence of abnormal Doppler FVWs in both donors and 
recipients prior to laser surgery. Of all fetuses, both alive and demised, 25.3% of 
donors and 6.2% of recipients had A/REDF in the UA prior to laser surgery. Abnormal 
DV FVW was found in 9.7% of donors and 28.3% of recipients. In 6.9% of donors and 
35.6% of recipients pulsations in the umbilical vein were present. An elevated middle 
cerebral artery peak systolic velocity (MCA-PSV) prior to surgery was reported in 7.9% 
of donor twins and 2.4% in recipient twins. 
Variables associated with fetal demise in recipient twins were: A/REDF in the UA, 
absent or reversed a-wave in the DV and MCA-PSV >1.5MoM (Multiples of the 
Median, Figure 2). Pulsatile flow in the umbilical vein was seen in over one-third of 
recipients but this did not increase the risk of recipient IUFD (OR 1.50, 95% CI: 0.98-
2.29). In donors, only A/REDF in the umbilical artery and absent or reversed a-wave 
in the DV were associated with IUFD (Figure 3). An elevated MCA-PSV in the donor 
almost doubled the risk of demise, but this finding did not reach significance (OR 
1.91, 95% CI: 0.97-3.76). Three studies reported the odds of donor demise for AEDF 
and REDF in the UA separately.28-30 All three studies concluded that REDF in the UA 
was the strongest predictor of donor demise. Many studies included in this review 
were underpowered to detect a difference in IUFD rate of donors and recipients with 
abnormal DV FVW. No study except for the study by Ishii et al26 found a significant 
association between preoperative abnormal DV FVW and donor demise. By pooling 
the data in this meta-analysis, we were able to find an association between abnormal 
DV FVW and an increased risk of IUFD of both donors and recipients. 
In the included studies, additional variables were also investigated. Kontopoulos et 
al.27 showed that the proportion of time in the cardiac cycle spent in AEDF (%AEDF) 
was significantly higher in patients with IUFD of the donor as compared to surviving 
donors (36.5% vs. 29.6%, p = 0.01). In a recent study by Delabaere et al.20 with 111 
patients, donors with early fetal demise (<7 days after laser surgery) had a lower MCA-
pulsatility index (PI) (1.43 vs. 1.65, p = 0.02), a higher UA-PI (2.03 vs. 1.59, p = 0.05) 
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and a lower cerebroplacental ratio (0.81 vs. 1.11, p = 0.01) as compared to donors 
who survived the first week after surgery. Two other studies were not able to confirm 
these findings.21,29 
Results of individual studies on echocardiography in relation 
to IUFD
In seven studies echocardiographic findings were analyzed in relation to IUFD.19-
21,28,29,32,33 We could only perform a meta-analysis on atrioventricular regurgitation. The 
presence of this finding was not associated with a higher risk of either donor (OR 1.34, 
95% CI, 0.39-4.62) or recipient demise (OR 1.20, 95% CI, 0.79-1.83).20,21,28 
The substantial methodical heterogeneity prevented the construction of other forest 
plots, we therefore present a summary of outcomes for other echocardiographic 
parameters. Five studies assessed the preoperative myocardial performance index 
(MPI) as a separate parameter 19,20,29,32,33, of which two report an increased risk of 
recipient demise.20,33 In a study of 105 recipients33 the risk of recipient demise was 4 
times higher if the MPI z-score was above a cut-off z-score of 1.645, which corresponds 
to the 95th percentile (p < 0.01). After adjustment for gestational age and placental 
localization, there was no increased risk (OR 3.09, 95% CI: 0.94 - 9.30, p = 0.06). In the 
most recent study by Delabaere et al.20 demised recipients had a higher mean MPI of 
the right ventricle (RV-MPI) as compared to survivors after adjustment for gestational 
age at laser surgery (unadjusted p = 0.07, adjusted p = 0.02). The three remaining 
studies did not find an association between preoperative MPI and postoperative 
recipient demise.19,29,32 The results are therefore conflicting. An association between 
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In three studies the CHOP (Children’s Hospital of Philadelphia) score35 (a sum of 12 
cardiovascular parameters, including the MPI) was analyzed in relation to IUFD.20,28,33 A 
CHOP score above 5 is generally considered as abnormal. Interestingly, only a CHOP 
score ≥ 3 was associated with recipient demise (40% with a score ≥ 3 vs 13% with a 
score < 3, p < 0.01)33 and a score > 5 was not.20 In the study of 466 TTTS cases, ‘global 
cardiac dysfunction’ was included in the analysis, a factor defined as an abnormal 
MPI, ventricular dyskinesia, abnormal ejection fraction, abnormal CHOP score (or 
other measure of cardiac dysfunction; exact cut-off values for separate parameters 
were not stated). The presence of “global cardiac dysfunction” prior to surgery did not 
increase the risk of either donor or recipient demise.28   In a small study by Leduc et 
al.32 of 55 treated pregnancies the aortic isthmus flow velocity patterns were assessed. 
The isthmic systolic index36, which reflects the relative performances of the right and 
left ventricle, measured in recipients before laser was associated with recipient IUFD 
(p = 0.04).
Discussion
In this systematic review and meta-analysis we found an association between 
preoperative Doppler FVWs and IUFD after fetoscopic laser coagulation. Fetal 
echocardiographic parameters such as the MPI appear not to be associated with fetal 
demise after laser coagulation. Results from studies investigating echocardiographic 
parameters do almost reach significance however, possibly indicating lack of power 
in these studies. The conflicting results regarding the use of echocardiography in the 
prediction of demise prevented us from building a prediction model including both 
Doppler and echocardiographic parameters. 
We have shown an IUFD rate of 19% for donors and 13% for recipients in the 
last decade. Improved survival after laser surgery may reflect a learning-curve 
effect of the operators,6,37 who gain more experience with this procedure globally. 
Furthermore, evolution of the technique38 and developments and improvements in 
ultrasonographic monitoring may play a role. The investigation of these factors on 
fetal survival rates fell outside of the scope of this article. 
We found that A/REDF in the UA, absent or reversed a-wave in the DV and MCA-
PSV >1.5MoM increases the risk of recipient IUFD. Abnormal UA FVW, present in only 
6% of recipients, may result from placental compression by increased intra-amniotic 
pressure due to massive polyhydramnios or, alternatively from poor cardiac function. 
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▼Figure 2. Doppler flows in the recipient twin
PEDF or A/REDF in UA, positive or absent/reversed end diastolic flow in the umbilical artery; P or A/E 
a-wave in DV, positive or absent/reversed a-wave in the ductus venosus; UV, umbilical vein; MCA-PSV, 
middle cerebral artery-peak systolic velocity
Fetal demise after laser treatment: a systematic review and meta-analysis
39 
II
▼Figure 3. Doppler flows in the donor twin
PEDF or A/REDF in UA, positive or absent/reversed end diastolic flow in the umbilical artery; P or A/E 
a-wave in DV, positive or absent/reversed a-wave in the ductus venosus; UV, umbilical vein; MCA-PSV, 
middle cerebral artery-peak systolic velocity
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A suggested theory is that poor myocardial contractility as a result of recipient 
hypervolemia and cardiac overload, result in an insufficient  generated blood 
pressure to propel the blood forward in the UA throughout diastole.20 The theory 
that poor cardiac function causes A/REDF flow in the umbilical artery in recipient twins 
is further supported by the finding that recipient twins with abnormal UA FVW always 
have abnormal venous FVW of the umbilical vein, ductus venosus, or both.18 More 
than one-third of recipients had a pulsatile umbilical vein preoperative, which could 
also indicate cardiac overload. This parameter was however not statistically significant 
associated with recipient demise. The mechanism underlying the association 
between increased MCA-PSV and IUFD in recipients is not entirely clear. Increased 
cardiac output resulting from the hypervolemic status of these fetuses, which is 
responsible for cardiomegaly and hypertrophy in some TTTS cases, could also elevate 
the blood velocity in the cerebral arteries. These changes have also been shown in 
fetuses with congenital heart disease39 or intrauterine growth restriction.40 Another 
suggested explanation is decreased fetal oxygenation due to placental interstitial 
edema which increases MCA blood velocity through autoregulation in the absence of 
low hemoglobin.29,41
In donors, only A/REDF in the UA and absent or reversed a-wave in the DV were 
found to be associated with donor-IUFD. In these twins, the mechanism leading to 
hemodynamic changes appears to differ from the pathophysiology in recipient twins. 
Abnormal UA FVW occurs in a quarter of donors prior to laser surgery. If present, the 
odds of demise are 3.4 times higher as compared to fetuses who have a normal UA 
FVW. It reflects both placental insufficiency (maldevelopment and unequal sharing) 
and fetal hypotension secondary to the hemodynamic imbalance in TTTS. Three 
studies showed that REDF in the UA is a stronger predictor of donor IUFD than 
AEDF.28-30 It is suggested that reversed UA flow reflects placental insufficiency in a 
greater degree and that it is not amenable to improvement following restoration of 
volume status.29 Abnormal venous FVW in donor twins may be explained by either 
cardiac decompensation due to severe placental insufficiency or hypovolemia as a 
result of the TTTS. The relative hypervolemia after occlusion of vascular anastomoses 
may increase the afterload and cause acute transient impaired cardiac function which 
attributes to a higher chance of donor demise after surgery. Elevated MCA-PSV prior 
to surgery is reported in 8% of donor twins. In monochorionic twins, unbalanced net 
intertwin blood transfusion may lead to TTTS, but also to twin anemia polycythemia 
sequence (TAPS). In TAPS, there is a chronic and slow transfusion of blood from the 
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donor to the recipient twin through extremely small anastomoses.42 This process 
leads to an anemic donor and polycythemia in the recipient. 2-8% of TTTS cases 
may have preoperative signs of TAPS,43 which may explain the increased MCA-PSV in 
donors prior to laser surgery. Although there was a tendency for donor twins with an 
elevated MCA-PSV to die more frequently in utero after surgery this finding did not 
reach statistical significance.
The question whether echocardiographic parameters should be included in the 
TTTS staging system remains unanswered. Most studies investigating the association 
between assessment of cardiac function and IUFD include neonatal demise instead of 
fetal demise as their endpoint.44-49 A large amount of data reflecting cardiac function 
had therefore been excluded from this systematic review. Furthermore, the limited 
amount of available reports on the value of a detailed cardiovascular assessment in 
the prediction of fetal survival provide discordant results. Three out of five studies 
did not find any genuine correlation with IUFD.19,29,32 The lack of correlation between 
severity of cardiac disease and intrauterine demise is not explained so far. The low 
reproducibility and repeatability indices of the MPI and a high degree of expertise 
needed to perform MPI or CHOP score measurements may be important factors. 
Very precise recordings and manual placement of calipers are needed for MPI 
calculations. For the left ventricle, the Doppler cursor is placed between the mitral 
valve and aortic valve and both mitral inflow and aortic outflow can be visualized 
on the same trace. Measurement of the RV-MPI is further complicated because the 
right ventricular inflow and outflow cannot be visualized in one plane and thus not in 
the same trace. Published normal ranges for different gestational ages demonstrate 
a wide variation,50-54 probably because a standardized method has not been 
established. While automation of these measurements will remove the human factor 
on measurement error, experience is still required to be able to acquire the correct 
Doppler waveform successfully.55,56 The lack of correlation may also be explained 
by the effectiveness of laser surgery for improving recipient cardiac function. Other 
variables associated with laser surgery such as premature rupture of membranes, 
unequal placental share and preterm delivery become the predominant determinants 
of fetal mortality after correction of the hemodynamic imbalance. 
To our knowledge, this is the first review and meta-analysis of pre-operative 
echocardiography and Doppler in the prediction of IUFD after fetoscopic laser surgery. 
To maximize our sample size, we included all studies which investigated fetal demise 
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before birth, not only early-IUFD (<7 days). Other causes of demise such as placental 
insufficiency or IUGR could therefore have influenced our results, even though the 
majority of IUFD after laser occurs in the first week after laser surgery.7,21,26 There are 
also other limitations to this study. Most studies are single center reports. Half of 
the reports are retrospective studies. In all but one study30 selective coagulation was 
used for all or for a proportion of cases. It is known that incomplete laser coagulation 
is a risk factor for recurrent TTTS or post-laser TAPS and therewith for possible 
subsequent fetal demise.57 Finally, we did not include fetal growth discordance, 
selective intra-uterine growth restriction (sIUGR) or TAPS prior to laser surgery in 
this study. Future large-scale prospective studies could allow for multivariate analysis 
into the interference of sIUGR and TAPS on fetal echocardiography and Doppler 
parameters for IUFD. Incorporating signs of sIUGR and TAPS, but also factors such 
as Quintero stage, hydrops and gestational age at TTTS diagnosis, into a prediction 
model together with the before mentioned Doppler parameters could be useful in 
daily clinical care in cases where the risk of fetal demise turns out to be high, to spend 
additional counseling time on cord occlusion as a back-up plan if laser surgery seems 
technically challenging. A prediction model could also be useful in future clinical trials 
investigating innovations in treatment of TTTS.
Conclusion
In conclusion, we have identified a set of preoperative Doppler parameters predictive 
of fetal demise after fetoscopic laser coagulation. Recipient twins have an increased 
risk of demise in case of preoperative abnormal FWV of the UA, DV and MCA. In donor 
twins, only abnormal FVW of the UA and DV are associated with IUFD after surgery. 
The utility of preoperative parameters that reflect cardiac function such as the MPI in 
predicting IUFD remains unclear.
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CHAPTER III
Prediction of single fetal demise  






Single fetal demise (SFD) occurs in up to 20% of monochorionic pregnancies treated 
with laser coagulation for  twin-twin  transfusion syndrome (TTTS). We aimed to 
determine the independent factors associated with SFD to improve outcome in the 
care of TTTS pregnancies in the future.
Methods  
This was a case-control study on twin pregnancies treated for TTTS between 2007 
and 2013. Data on ultrasound, laser surgery and outcome were retrieved from our 
monochorionic  twin  database. We analyzed separately cases of SFD in donor and 
recipient  twins, and compared them with treated pregnancies that resulted in two 
live births.
Results  
Of the 273 TTTS pregnancies treated with laser coagulation, SFD occurred in 30 
donors (11.0%) and 27 recipients (9.9%). In 67% of pregnancies with SFD, the death 
occurred within 1 week after laser treatment. For SFD in donors, absent/reversed end-
diastolic flow in the umbilical artery was the strongest predictor (odds ratio (OR), 3.0 
(95% CI, 1.1-8.0); P = 0.01), followed by the presence of an arterioarterial anastomosis 
(OR, 4.2 (95% CI, 1.4-13.1); P = 0.03) and discordance in estimated fetal weight (OR, 
1.0 (95% CI, 1.0-1.1); P = 0.04). For SFD in recipients, independent predictors were 
absent/reversed A-wave in the ductus venosus (OR, 3.6 (95% CI, 1.2-10.5); P = 0.02) 
and the absence of recipient-to-donor arteriovenous anastomoses (OR, 10.6 (95% CI, 
1.8-62.0); P < 0.01).
Conclusion  
Our findings confirm earlier reports that suggest that abnormal blood flow is 
associated with SFD after laser treatment for TTTS. The association of SFD with the 
type of anastomoses is a new finding. We speculate that the type of anastomoses 
present determines the degree of hemodynamic change during laser therapy. Future 
strategies should aim at stabilizing fetal circulation before laser therapy to decrease 
the vulnerability to acute preload and afterload changes.




Monochorionic–diamniotic (MCDA) pregnancy has a higher risk of adverse fetal or 
neonatal outcome than does twin pregnancy in general, owing to a higher incidence 
of congenital malformations and pregnancy complications as a result of placental 
angioarchitecture. In 10–15% of MCDA twin pregnancies, imbalanced blood flow 
through the communicating vessels in the shared placenta causes a net transfusion 
from one twin (donor) to the other twin (recipient), known as twin–twin transfusion 
syndrome (TTTS). Overall mortality rate in fetuses with TTTS has been reported to be 
as high as 90% if left untreated.1,2 Laser coagulation of the anastomoses that develop 
in TTTS decreases the mortality rate to approximately 40% in donors and 30% in 
recipients.3
Double, often simultaneous, fetal demise after laser surgery occurs in up to 20% of 
treated pregnancies,4,5 caused by a variety of complications. Many of these causes 
are well understood, such as intrauterine bleeding, rupture of membranes, infection, 
miscarriage, technical complications and incomplete procedures.
Single fetal demise (SFD), however, often occurs unexpectedly after otherwise 
uneventful surgery. The identification of factors that are associated with unexplained 
SFD could help to explain the pathophysiological processes that play a role in this event. 
Several ultrasonographic findings, such as abnormal flow in the ductus venosus (DV) 
or the umbilical artery, have been associated with SFD.4 This reflects a hemodynamic 
challenge for fetuses with TTTS. TTTS is treated by laser coagulation of the vascular 
anastomoses to restore hemodynamic balance. Placental angioarchitecture is 
different in all monochorionic placentae, and different types of anastomosis might 
cause different hemodynamic challenges, which could be a factor in fetal demise after 
laser therapy. The aim of this study was to determine the independent risk factors 
concerning ultrasonographic and angioarchitectural findings in unexplained SFD 
after laser surgery for TTTS. Further insight into the hemodynamics of TTTS could 
initiate the start of the development of interventions with the aim of improved fetal 




The Leiden University Medical Center is the national referral center for invasive fetal 
therapy in The Netherlands. Data on all consecutive pregnancies diagnosed with TTTS 
and treated by laser surgery between January 2007 and July 2013 were reviewed. 
Data concerning ultrasonographic findings, operative characteristics, postpartum 
placental examination and neonatal follow-up were entered prospectively into the 
monochorionic twin database. SFD was defined as demise of one twin at any time after 
laser therapy and before the onset of labor. Case–control analysis was performed 
separately for donors and recipients. TTTS cases treated with laser coagulation and 
resulting in the live birth of both twins were used as controls.
In all pregnancies, gestational age was calculated on the basis of crown–rump 
length at first-trimester ultrasound. TTTS was diagnosed according to the Eurofetus 
criteria and defined as polyuric polyhydramnios in the recipient twin with a deepest 
vertical pocket of 8 cm before 20 weeks’ gestation and 10 cm after 20 weeks, and 
simultaneously, oliguric oligohydramnios in the donor twin with a deepest vertical 
pocket of less than 2 cm.6 Severity of the disease was classified according to the 
Quintero staging system.7 Indications for performing laser surgery were Quintero 
Stage II–IV or Stage I with symptomatic polyhydramnios. Exclusion criteria for analysis 
were chromosomal abnormalities or major congenital malformations, intrauterine 
fetal demise (IUFD) of both twins or IUFD attributable to labor. Cases of selective 
feticide were also excluded.
A comprehensive preoperative ultrasound examination was always performed 
before laser treatment in our unit to confirm and stage the TTTS. Signs of fetal cardiac 
adaptation or compromise were evaluated. Discordance in estimated fetal weight 
(EFW) was calculated as (recipient EFW − donor EFW)/(recipient EFW) × 100%.
The placenta was examined after birth by injecting colored dye, as described 
previously.8,9 Under local anesthesia with adjuvant intravenous analgesia and mild 
sedation with fentanyl and midazolam, fetoscopic laser surgery was performed by 
one of five experienced fetal surgeons. Patients were treated with sequential selective 
laser coagulation of all communicating vessels, with coagulation of the whole vascular 
equator (the Solomon technique)9 or without this additional coagulation. During laser 
therapy, the number and type of coagulated anastomoses were recorded and used for 
analysis. After laser therapy, patients remained in hospital for about 24 h. Ultrasound 
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examination was performed the following morning and approximately 1 week after 
laser therapy. Biweekly follow-up scans were scheduled after the first week until birth 
for all patients, and the placenta was examined postnatally to determine the site of 
cord insertion. In the majority of SFD cases, dye injection was not feasible owing to 
maceration of the placental share of the deceased fetus.8,10
Neonatal cerebral ultrasound of the surviving twin after SFD was performed 
routinely after birth. Severe cerebral injury was defined as the presence of at 
least one of the following findings on cranial imaging: intraventricular hemorrhage 
≥ Grade III,11 periventricular leukomalacia ≥ Grade II,12 (progressive and non-
progressive) ventricular dilatation ≥ 97th percentile13 and arterial or venous infarct or 
other cerebral anomalies associated with adverse neurological outcome.14
Data were stored and statistical analysis was carried out with the IBM SPSS 20.0 
statistical package (IBM, Chicago, IL, USA). Using univariable logistic regression analysis, 
preselection of variables for the prediction of SFD was performed to select those 
for inclusion in the subsequent multivariable analysis. Logistic regression analysis 
was performed separately for SFD of donors and recipients. Variables with P ≤ 0.10 
were considered for inclusion in the multivariable analysis. For analysis, absent and 
reversed end-diastolic flow (A/REDF) in the umbilical artery was clustered as one 
variable because of the low prevalence of REDF in the cohort. Absent and reversed 
A-wave in the DV were clustered as one variable because of low prevalence of absent 
A-wave in the cohort. Variables with a very low prevalence or too many missing values 
were omitted from the analysis.
A multivariable model was constructed to identify independent predictors of SFD in 
donors and in recipients, using backward stepwise elimination. Variables with P < 0.05 
remained in the final model. For all associations in the model the odds ratios (OR) and 
their 95% CIs were computed.
Results
In the study period, a total of 288 pregnancies were referred to our hospital for 
TTTS. An overview of the total cohort is shown in Figure 1. Four cases were excluded 
because of chromosomal or major congenital abnormalities. Laser coagulation was 




Figure 1. Flowchart of monochorionic-diamniotic twin pregnancies that underwent laser 
therapy for twin-twin tranfusion syndrome (TTTS)
In 282 pregnancies laser coagulation of the communicating vessels was attempted. 
Three cases were lost to follow-up and excluded from the analysis. In six cases that 
appeared suitable for laser therapy, umbilical cord coagulation was performed 
instead owing to technical complications (Table 1). 
A total of 273 pregnancies received laser therapy for TTTS. Of these, 138 (50.5%) 
also participated in the Solomon trial.9 A total of 120 (48%) pregnancies were treated 
with the Solomon technique. Table 2 shows the characteristics of the cohort treated 
with laser therapy according to their outcome. The mean ± SD gestational age at the 
time of laser procedure was 20.0 weeks ± 3.0 days. SFD occurred in 11.0% (30/273) 
of donors and in 9.9% (27/273) of recipient twins. The majority of SFD was detected 
within 1 week after laser surgery in 60.0% (18/30) of donor SFD and in 74.1% (20/27) 
of recipient SFD. Double fetal demise occurred in 4.0% (11/273) and the pregnancy 
ended in miscarriage with no survivors in 4.8% (13/273). Live birth of both twins 
occurred in 70.3% (192/273) of pregnancies, providing 249 pregnancies for inclusion 
in the analysis.
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Table 1. Technical complications that resulted in umbilical cord coagulation instead of the 
intended laser therapy in six fetuses with twin-twin transfusion syndrome





1 R II 17+0 Uterus subseptus, hemorrhage at trocar inser-
tion, donor blocking vascular equator
2 R III 15+4 Insufficient visualization owing to amnion dehis-
cence in early pregnancy
3 R IV 22+0 Hemorrhage on trocar insertion, insufficient 
visualization
4 R III 18+0 Donor blocking vascular equator
5 D III 16+0 Difficult visualization in early pregnancy and 
obese patient; laser therapy difficult to maintain 
due to major velamentous anastomoses
6 R II 19+2 Donor blocking vascular equator
R, recipient; D, donor; Q, Quintero stage; GA, gestation age at procedure
Table 2. Baseline characteristics of 273 pregnancies with twin–twin transfusion syndrome (TTTS) 
treated with laser therapy, according to survival outcome
No IUFD sIUFD donor sIUFD reci-
pient
IUFD double All
(n = 192) (n = 30) (n = 27) (n = 24) (n = 273)














30.3 ± 4.8 31.2 ± 4.9 32.4 ± 4.7 31.3 ± 6.2 30.6 ± 5.0
Stage of TTTS
I 19 (9.9) 3 (10) 2 (7.4) - 24 (8.8)
II 63 (32.8) 8 (26.7) 5 (18.5) 5 (20.8) 81 (29.7)
III 102 (53.1) 19 (63.3) 19 (70.3) 19 (79.2) 159 (58.2)
IV 8 (4.2) - 1 (3.7) - 9 (2.5)
Laser-to-IUFD 
interval 
<24hrs - 13 (43.3) 15 (55.5) 6 (25.0)*
24 h to7days - 5 (16.7) 5 (18.5) 4 (16.7)
>7 days - 12 (40.0) 7 (25.9) 11 (45.8)












Data are presented as median (interquartile range), mean ± SD or n (%).   
* In 3 cases of double demise there was unequal time of demise of both twins
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Table 3  summarizes the incidence of potential risk factors for SFD in donors and 
recipients, and values are compared with those in controls (live birth of both twins). 
The results of multivariable analysis for the identification of predictors of SFD in donor 
and recipient twins are shown in Tables 4 and 5, respectively. Variables associated 
with SFD of donor twins after univariable analysis were: EFW discordance, A/REDF in 
the umbilical artery, presence of arterioarterial (AA) anastomoses detected during 
fetoscopy and lower gestational age at the procedure.




(n = 30) p-value*
SFD recipient
(n = 27)          p-value*
Basic parameters







Anterior placenta 63 (32.8) 10 (33.3) 0.96 12 (44.4) 0.24
EFW discordance (%) 18.0 ± 13.2 27.1 ± 10.8 < 0.01 19.7 
Ultrasound parameters  in recipient
Deepest vertical pocket  
(mm)
98.4 ± 33.4 93.7 ±22.7 0.46 102.6 ±34.6 0.55
A/REDF UA 6 (3.1) 1 (3.4) 0.98 3 (12.5) 0.06
MCAPSV >1.5 MoM 0 0 - 0 -
Pulsatile UV 69 (49.3) 11 (44.0) 0.63 15 (71.4) 0.07
A/R atrial flow DV 35 (18.2) 3 (10.0) 0.22 10 (37.0) 0.02
Cardiomegaly 43 (22.5) 8 (26.7) 0.62 5 (18.5) 0.64
Ascites 8 (4.2) - - 1 (3.7) 0.90
Pericardial effusion 7 (3.7) 3 (6.7) 0.44
Pleural effusion 2 (1.0) - - 1 (3.7) 0.30
Subcutaneous oedema 3 (1.6) - - - -
Ultrasound parameters  in donor
Bladder not visible 37 (20.3) 9 (31.0) 0.20 1 (4.2) 0.09
A/REDF UA 43 (22.4) 14 (46.7) <0.01 8 (32.0) 0.02
MCAPSV >1.5 MoM 7 (4.2) 2 (7.4) 0.47 3 (12.5) 0.11
Pulsatile UV 22 (17.7) 4 (18.3) 0.96 3 (15.0) 0.76
A/R atrial flow DV 11 (5.7) 3 (10) 0.44 1 (4.5) 0.69
Cardiomegaly 9 (4.7) 3 (10.0) 0.24 - -
Ascites 1 (0.5) - - - -




22 (11.8) 1 (4.0) 0.25 6 (25) 0.05






(n = 30) p-value*
SFD recipient
(n = 27)          p-value*
Velamentous cord inser-
tion (donor)
41 (21.8) 5 (22.7) 0.24 2 (9.5) 0.16
Presence of AA anasto-
moses
15 (8.1) 9 (33.3) <0.01 2 (8) 0.99
Absence of AVRD 5 (2.7) 2 (7.4) 0.22 4 (15) <0.01
Laser therapy characteristics
Solomon technique 93 (48.4) 17 (56.7) 0.40 10 (37.0) 0.11
PPROM < 14 days after 
procedure
10 (5.2) 3 (10.0) 0.31 2 (7.4) 0.64
Intrauterine bleeding 
during procedure
3 (1.6) 2 (6.7) 0.11 1 (3.7) 0.45
Values are given as median (interquartile range), mean ± SD or n (%). Data were not available in all 
cases; percentages reflect this. *Compared to controls. AA, arterioarterial; A/R, absent or reversed; 
A/REDF, absent or reversed end-diastolic flow; AVRD, arteriovenous anastomoses from recipient to 
donor; DV, ductus venosus; EFW, estimated fetal weight; GA, gestational age; MCA-PSV, middle cerebral 
artery peak systolic velocity; MoM, multiples of the median; PPROM, preterm prelabor rupture of 
membranes; UA, umbilical artery; UV, umbilical vein.
Lower gestational age at the procedure was excluded from analysis because it 
showed correlation with abnormal flow in the umbilical artery, and priority was given 
to the clinically relevant variable of blood flow over gestational age. After multivariable 
analysis, independent risk factors for SFD in donor twins were: A/REDF in the umbilical 
artery (OR, 3.0 (95% CI, 1.1–8.0); P = 0.01), presence of AA anastomoses (OR, 4.2 (95% CI, 
1.4–13.1); P = 0.03) and discordance in EFW (OR, 1.0 (95% CI, 1.0–1.1); P = 0.04).
Variables associated with SFD in recipient twins were: A/REDF in the umbilical artery 
in one or both twins, absent or reversed A-wave in the DV and pulsatile flow in the 
umbilical vein of the recipient twin, velamentous cord insertion for the recipient and 
absence of recipient-to-donor arteriovenous (AVRD) anastomoses. Pulsatile flow in 
the umbilical vein was excluded from the analysis as there were too many missing 
values, which impedes multivariable analysis. After multivariable analysis, absent or 
reversed A-wave in the DV (OR, 3.6 (95% CI, 1.2–10.5); P = 0.02) and absence of AVRD 
anastomoses (OR, 10.6 (95% CI, 1.8–62.0); P < 0.01) remained independent factors for 
SFD of the recipient twin.
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Table 4. Univariable and multivariable logistic regression model analysis to identify predictors of 
single fetal demise in donor twin after laser therapy for twin-twin transfusion syndrome
Variable Univariable Multivariable 
OR (95% CI) P-value OR (95% CI) P-value
GA at procedure 0.97 (0.95-0.99) 0.01
EFWD 1.06 (1.02-1.10) <0.01 1.04 (1.00-1.09) 0.04
AREDF UA 5.19 (2.31-11.78) <0.01 2.95 (1.08-8.03) 0.01
Presence AA anastomoses 5.59 (2.23-13.98) <0.01 4.21 (1.36-13.06) 0.03
SFD, single fetal demise; GA, gestational age; EFWD, estimated fetal weight discordance; AREDF, absent 
or reverse end diastolic flow; UA, umbilical artery; AA, arterio-arterial anastomoses.
Complications of laser treatment, such as intrauterine bleeding or ruptured 
membranes within 2 weeks after treatment, did not differ significantly between 
controls and SFD groups. Neonatal death occurred in 2/30 (6.7%) recipients. Both 
were delivered before 26 weeks’ gestation; one had severe cerebral injury, but no 
cerebral imaging was performed in the other. One case was lost to neonatal follow-up. 
Severe cerebral injury in surviving recipients was found in 1/27 (3.7%); gestational age 
at delivery was 25 weeks. One recipient had no abnormalities on neonatal cerebral 
ultrasound but showed neurodevelopmental impairment at the follow-up visit at 
2 years of age. Neonatal death occurred before cerebral imaging was performed in 
2/27 (7.4%) donors; both were delivered before 26 weeks’ gestation. Severe cerebral 
injury was not found in any of the surviving donors. One case was lost to follow-up.
Table 5. Univariable and multivariable logistic regression model – recipient
Variable Univariable Multivariable 
OR (95% CI) P-value OR (95% CI) P-value
Velamentous cord inser-
tion (recipient)
3.03 (1.00–9.19) 0.05    
A/REDF in UA (recipient) 4.10 (0.95–17.60) 0.06   NS
A/REDF in UA (donor) 2.61 (1.03–6.61) 0.04   NS
A/R A-wave in DV 3.06 (1.24–7.54) 0.02 3.59 (1.23–10.51) 0.02
Pulsatile UV (recipient) 2.57 (0.94–7.01) 0.07   NS
Absence of AVRD 6.86 (1.71–27.56) < 0.01 10.59 (1.81–62.02) < 0.01
A/R, absent or reversed; A/REDF, absent or reversed end-diastolic flow; AVRD, arteriovenous recipient-
to-donor anastomoses; DV, ductus venosus; OR, odds ratio; UA, umbilical artery; UV, umbilical vein.




In this study, predictors of SFD following laser surgery for TTTS were abnormal 
Doppler flow profiles and the type of anastomoses present at the time of treatment. 
Our results for overall survival rate are consistent with those of previous reports.3-5,15,16 
Rates of severe cerebral injury of the surviving twin following SFD were comparable 
with those of overall cerebral injury in TTTS laser therapy.17-19
Abnormal Doppler flow
A/REDF in the umbilical artery for donors and abnormal A-wave in the DV for recipients 
were found to be independent risk factors for SFD, both reflecting Quintero-Stage-III 
TTTS. A/REDF is a known predictor of demise of the donor and is thought to reflect 
hypotension secondary to TTTS.4,16,20,21 Acute hemodynamic changes take place when 
the communicating vessels are coagulated. Gratacós et al.22 evaluated the impact of 
fetoscopic laser coagulation within the first days after the procedure, and found that 
up to 50% of donors with abnormal flow in the umbilical artery showed reappearance 
of positive EDF in the umbilical artery within 1 week. However, up to 25% of donors 
developed transient tricuspid valve insufficiency or hydropic signs owing to relative 
hypervolemia after laser treatment.22 We speculate that in more severely compromised 
donor fetuses, sudden restoration of volume status can cause fetal demise. This 
hypothesis is supported by the studies of Eixarch et al.15 and Skupski et al,5 who found 
only REDF in the umbilical artery as a risk factor for fetal demise and not AEDF. They 
considered that REDF reflects a more severe degree of compromise in TTTS.
In recipient twins, an absent/reversed A-wave in the DV was an independent risk factor 
for fetal demise. This is in agreement with studies of Skupski et al.5 and Zikulnig et al.23 
An abnormal A-wave in the DV is suggestive of increased central venous/right atrial 
pressure, thus cardiac compromise, probably due to hypervolemia with increased 
end-diastolic ventricular pressure. In more advanced stages this may result in cardiac 
dysfunction and fetal hydrops. It has been postulated that acute restoration of volume 




We identified the presence of AA anastomoses as a risk factor for SFD in donors and 
the absence of AVRD anastomoses for SFD in recipients. This association has not been 
described previously. AA anastomoses are thought to equalize blood flow between 
fetuses and protect against TTTS. They are accompanied by branching vessels that 
enter the cotyledon 
of the recipient or donor twin. The function of the AA anastomosis depends on 
where the hemodynamic equator lies. Depending on whether the AA anastomosis 
is located on the donor or recipient side, it serves as a functional AVRD or donor-to-
recipient arteriovenous (AVDR) anastomosis. AA anastomoses occur in 19–37% of 
TTTS cases, compared with 91% of uncomplicated MC twin pregnancies.24-26 Umur et 
al.27 claimed that AA anastomoses protect against TTTS more frequently than do 
AVRD anastomoses of similar size because of a smaller resistance. We hypothesize 
that if AA anastomoses are unable to prevent TTTS, they might make an important 
contribution to causing the disease by behaving as a strong functional arteriovenous 
anastomosis. This is in agreement with the findings of a small study by Murakoshi et 
al,25 who showed unidirectional flow in 93% of AA anastomoses in a cohort of 14 TTTS 
cases. Interestingly, unidirectional flow could be from donor to recipient or vice versa, 
suggesting that AA anastomoses can play either a causal role or a compensating 
role in TTTS. In our study we could not investigate flow in AA anastomoses, therefore 
the function of the coagulated AA anastomoses in these cases is unknown. SFD in 
the presence of an AA anastomosis can be explained by the hypothesis that acute 
hemodynamic changes at the time of laser surgery are more profound in these cases.
AVRD anastomoses establish blood flow from recipient to donor and therefore 
compensate for AVDR anastomoses in TTTS. In our study, absence of these vessels 
was found in 14.8% (4/27) of dead recipients and was associated with SFD in recipients. 
The pathogenesis of this phenomenon is not well understood. Hypothetically, 
recipients, in the absence of AVRD anastomoses, face more hypervolemic challenges 
during TTTS than when the vessels are present, resulting in more profound volume 
changes after laser therapy, which might result in fetal demise. On the other hand, 
sample size was limited and more research is needed to confirm this finding.
Abnormal Doppler flow, as defined in Quintero Stage III, is a strong predictor of SFD, 
reflecting more profound hemodynamic challenges in pregnancies with TTTS. Fetal 
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survival might improve through the training of referral-center personnel, to achieve 
timely referral and treatment. Furthermore, the type of anastomoses present at the 
time of TTTS appears to play an important role in SFD. We speculate that the type 
of anastomoses determines the degree of hemodynamic change that occurs during 
laser therapy. Although the exact pathogenesis is not fully understood, this knowledge 
provides us with the opportunity to investigate the options available to adapt our 
fetoscopic laser procedure in the future. Crombleholme  et al.28 and Zaretsky  et 
al.29 state that adjunctive medical therapy might improve the survival of recipient 
twins with signs of cardiomyopathy, and suggest further research on this topic. We 
speculate that vasoactive medication could prevent SFD through stabilization of the 
hemodynamics in both fetuses. This should be the subject of future research to 
improve survival after laser therapy for TTTS.
Strengths and limitations of the study
We believe that the strengths of our study are the separate evaluation of unexplained 
SFD in donors and recipients, as they face different challenges in TTTS, and the 
relatively large size of our consecutive cohort, which enabled analysis by logistic 
regression to assess the value of most variables as prognostic factors. Nevertheless, 
some potential predictors were limited in number, preventing robust conclusions to 
be made on their importance.
It can be difficult to recognize the type of anastomosis, but where possible this 
parameter was recorded during laser therapy. This constitutes a limitation of our study, 
especially as regards smaller arteriovenous anastomoses, while AA anastomoses are 
more easily recognized. The incidence of AA anastomoses in our study was 10.4%, 
which is low compared with previously reported values of up to 37% in postpartum 
placenta dye-injection examinations. Although these studies did not state whether 
laser therapy was performed and if fetal demise occurred, this could indicate an 




Abnormal blood flow patterns and the type of anastomoses present between twins 
are associated with SFD after laser treatment. Both parameters are a reflection of 
the hemodynamic challenges fetuses face in TTTS. Fetuses in more advanced stages 
of TTTS carry a higher risk of fetal demise, so early detection and well-timed therapy 
might improve fetal outcome. In addition, future studies should, on the one hand, 
focus on the role of different types of anastomoses in hemodynamic changes during 
laser therapy, and, on the other hand, focus on stabilization of the fetal circulation 
before and during laser treatment. This would provide opportunities to adapt our 
management of TTTS in order to decrease vulnerability to acute pre- and afterload 
changes and improve outcome.
.
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CHAPTER IV
Abnormal umbilical artery flows in 
appropriately grown monochorionic 
twins in relation to proximate cord 





To compare the prevalence of intermittent absent or reversed end-diastolic flow 
(iAREDF) in the umbilical artery in appropriately grown monochorionic diamniotic 
(MCDA) pregnancies with and without proximate cord insertion (PCI), and to evaluate 
pregnancy outcome
Methods  
The prevalence of iAREDF in MCDA pregnancies with PCI (n=11) was compared 
with a control group without PCI (n=33). PCI was defined as a distance between the 
cord insertions below the fifth percentile. Placental sharing, number, and diameter 
of anastomoses were assessed by placental examination. Pregnancy outcome was 
evaluated.
Results  
iAREDF was present in 7/11 PCI pregnancies, compared with 0/33 in the control 
group (p=<0.01). All PCI pregnancies and 94% of controls had arterio-arterial (AA)-
anastomoses (p=0.56), the diameter was larger in the PCI group, respectively 3.3 
versus 2.1 mm (p=0.03). Three cases with iAREDF had adverse outcome, two resulted 
in fetal death of which one with brain damage in the co-twin, another underwent early 
premature emergency section for fetal distress
Conclusion  
iAREDF occurs in a large proportion of MCDA pregnancies with PCI and is related to 
the diameter of the AA anastomosis. We hypothesize that iAREDF in appropriately 
grown MCDA twin pregnancies reflects an unstable hemodynamic balance with an 
increased risk for fetal deterioration. Whether outcome in these pregnancies can be 
improved by altered management requires further investigation.




Monochorionic diamniotic (MCDA) twins carry a high risk for specific pregnancy 
complications due to their shared placental circulation.1 Type, number and size of 
the vascular anastomoses on the placental surface influence the risk for twin-twin 
transfusion syndrome (TTTS), twin anemia polycythemia sequence (TAPS) and, when 
combined with an unequally shared placenta, selective intra-uterine growth restriction 
(sIUGR). A combination of a central and velamentous insertion is known to increase 
the risk for complications as well, especially in sIUGR pregnancies.2,3 
The assessment of Doppler waveforms in the umbilical artery is used to estimate 
the risk of adverse outcome in complicated monochorionic twins. A specific flow 
pattern, first described in 1994, is intermittent absent or reversed end-diastolic flow 
(iAREDF) in the smaller twin of sIUGR.4 This is attributed to a large arterio-arterial (AA) 
anastomosis that facilitates transmission of the systolic waveforms of one twin into the 
umbilical cord of the co-twin.5 The iAREDF reflects an unstable hemodynamic balance 
between the two fetuses,6,7 and the presence of iAREDF is associated with unexpected 
fetal death in cases with sIUGR.7,8 If single fetal death occurs in monochorionic twin 
pregnancies, this can result in severe cerebral injury or even fetal death in the co-
twin.9-11 
We observed several cases with iAREDF in MCDA twins in absence of TTTS, TAPS of 
sIUGR. In these pregnancies, cord insertions lied very close to each other on the 
placental surface, which is known as ‘proximate cord insertion’ (PCI). PCI occurs in 
3% of monochorionic diamniotic (MCDA) pregnancies and a large AA anastomosis 
is always present.9,12  Currently, it is unknown whether this specific subgroup is at 
increased risk of adverse pregnancy outcome such as known in sIUGR. The aim 
of our study was to assess the presence of iAREDF in appropriately grown MCDA 
pregnancies with and without PCI, in absence of TTTS, TAPS or sIUGR and evaluate a 
possible relation to pregnancy outcome.
Methods
The Leiden University Medical Center is the national referral center for complicated 
monochorionic twin pregnancies. Data on prenatal ultrasound, placental 
characteristics and neonatal outcome of all monochorionic twins born in our unit are 
prospectively entered in fetal and neonatal databases. Placentas of all monochorionic 
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twins are routinely injected with colored dye. Pictures of the placenta are taken with 
a measuring tape to allow measurements on the digital picture.13 To assess the 
relationship between PCI and iAREDF in MCDA pregnancies, we extracted all PCI cases 
based on placental examination after birth. We selected all pregnancies that received 
prenatal care, including ultrasonographic follow-up, in our unit, born between January 
2004 and June 2017. PCI was defined as a distance between the cord insertions below 
the 5th percentile, ranging from 3.3 to 4.0 cm across gestation.12  We excluded cases 
with TTTS, TAPS and sIUGR, as the aim of this study was to assess the prevalence 
of iAREDF in appropriately grown, uncomplicated monochorionic twin pregnancies. 
TTTS was defined using the Eurofoetus criteria and the Quintero staging system.14,15 
sIUGR was defined as an estimated fetal weight below the 10th percentile in one twin 
and an inter-twin difference of estimated fetal weight at ultrasound of >25%.7 When 
manifestation of sIUGR took place weeks after the initial finding of iAREDF, the case 
remained in the study in order to evaluate pregnancy outcome in cases with iAREDF 
in appropriately grown fetuses at time of examination. As control cases, we included 
all consecutive uncomplicated MCDA pregnancies between January 2013 and June 
2017 without PCI. The size of AA anastomosis and placental share discordance were 
measured on the placenta pictures. Placental share discordance was calculated as 
(larger placental area – smaller placental area)/(larger placental area)x100%.
All monochorionic pregnancies attending our clinic receive ultrasonographic 
examinations biweekly from 14 weeks gestational age onwards. In uncomplicated 
monochorionic twins, labor is induced at 36 weeks of gestation. We reviewed all 
ultrasound examinations of PCI cases and controls, including biometry and flow 
velocity waveforms of the umbilical artery in both twins. iAREDF in the umbilical 
artery was defined as the clear observation of absent and reversed end diastolic flow, 
alternating with positive diastolic flow over a short period of time, in the absence of 
fetal and maternal breathing.7 Ductus venosus flow was defined as normal when a 
positive a‐wave was present, and abnormal when absent or reversed a‐wave in the 
ductus venosus was seen. We assessed fetal survival, gestational age of delivery and 
birthweight (BW) discordance, the latter was calculated as (BW larger twin- BW smaller 
twin)/(BW larger twin) x100%. 
Statistical analysis was performed with IBM SPSS 25.0 statistical package. Categorical 
variables were analyzed using the independent-samples t-test, and a chi-square test 
was performed to analyze continuous variables. A p-value of <0.05 was considered 
statistically significant.
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▼Figure 1. Overview of umbilical artery flow in MCDA pregnancies with PCI
 
iAREDF, intermittent absent or reversed end-diastolic flow in the umbilical artery; MCDA, monochorionic 
diamniotic; PCI, proximate cord insertion; PEDF, positive end diastolic flow in the umbilical artery; 
TTTS, twin to twin transfusion syndrome
Results
We extracted 23 cases with an MCDA placenta with PCI in our placenta database. 
Twelve were excluded because of TTTS or sIUGR , thus 11 cases remained eligible 
for analysis. Thirty-three consecutive uncomplicated MCDA pregnancies without PCI 
were included as controls (see Figure 1).
In 64% (7/11) of PCI cases iAREDF was present, in the 33 control cases iAREDF was 
never encountered (p<0.01). Ductus venosus flows were normal in all cases. As shown 
in Table 1, the presence of AA anastomoses was comparable in both groups (p=0.56), 
but the diameter of the AA anastomosis in the PCI group was significantly larger 
than in controls (p=0.03). The majority of placentas showed only 1 AA-anastomosis. 
In the control group, 3 placentas were found with 2 AA-anastomoses, while 2 
placentas showed no AA-anastomosis. There were no other differences in placental 
characteristics between both groups. 
Table 2 summarizes the seven cases with iAREDF. In 4 cases the finding of iAREDF 
was transient and resolved in the third trimester. These cases resulted in a live 
birth of both twins after 34 weeks of gestation. In 3 of the 7 cases with iAREDF, fetal 
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deterioration occurred in the twin showing iAREDF. In the first case, unexpected fetal 
demise of this twin occurred at 20 weeks of gestation, despite absence of any sign of 
TTTS or sIUGR. Severe cerebral damage of the co-twin was found on follow-up scans, 
which was confirmed by fetal MRI. The parents chose to terminate the pregnancy at 
23 weeks of gestation. Figure 2 shows the iAREDF in the umbilical artery at 18 weeks 
of gestation in this case, Figure 3 shows the placenta with proximate cord insertion. 
The second case was referred for iAREDF in MCDA twins with concordant growth at 
20 weeks of gestation. Follow-up in the following weeks showed deteriorating fetal 
condition with frequent episodes of bradycardia. The estimated fetal weight of the 
iAREDF twin dropped from 30th percentile to below the 10th percentile within three 
weeks. Selective reduction of the iAREDF twin was chosen by the parents at 23 
weeks gestation. The surviving twin was born healthy at 37 weeks of gestation. In 
this case, placental color dye injection could not be performed due to maceration of 
the placental share of the demised twin. The third case was referred to our center 
at 27 weeks with iAREDF of gestation of twin A, but concordant growth of the twins. 
The patient was admitted for fetal monitoring. After five days, caesarean section was 
performed because of non-reassuring fetal tracings, resulting in two live born twins 
of 1070 and 910 grams, respectively. Postnatal placental examination showed a large 
AA anastomosis between the umbilical cord insertions. 






iAREDF in the umbilical artery of one twin, n (%) 7 (64) 0 (0) <0.01
Gestational age at delivery in weeks+days, median 
(IQR)
36+2 (34+2-36+6) 36+0 (35+4-36+3) 0.35
Fetal demise, n (%) 2 (18) 0 (0) 0.06
Birth-weight discordance in %, median (IQR) 7.4 (5.5-13.1)  10.7 (8.6-15.1) 0.28
Placental characteristics
Placental-share discordance in %, median (IQR) 17.7 (0-17.7) 29.5 (12.8-40.8) 0.56
Total number of anastomoses, median (IQR) 6 (4-11)) 11 (7-19) 0.20
Presence of AA anastomoses, n (%)† 11 (100) 31 (93.4) 0.56
Diameter of AA anastomoses in mm, median 
(IQR)
3.3 (2.9-5.9) 2.1 (1.1-2.8) 0.03
PCI, proximate cord insertion; iAREDF, intermittent absent and reversed diastolic flow;   
AA anastomosis, arterio-arterial anastomosis; IQR, interquartile range † In this small study, median 
interobserver difference was 0.1 mm (IQR 0.0-0.1) and median intraobserver difference was 0.1 mm 
(IQR 0.0-0.125). 
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▲Figure 2. iAREDF at 18 weeks of gestation in an equal size MCDA pregnancy
 
▲Figure 3. placenta of MCDA-pregnancy with PCI and fetal demise of iAREDF twin (case 1)
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1 18 Fetal demise 20 weeks, TOP 23 weeks † 23+5
2 20 UCC for fetal deterioration at 23 weeks ‡ 37+3 2950
3 27 § Caesarean section at 28 weeks ¶ 27+5 1070/910 15.0
4 16 iAREDF resolved after 31 weeks 36+3 2670/2160 18.8
5 16 iAREDF resolved after 24 weeks 36+1 2350/2220 5.5
6 18 iAREDF resolved after 26 weeks 36+2 2645/2350 11.2
7 22 iAREDF resolved after 26 weeks 34+2 1810/1765 2.5
MCDA, monochorionic diamniotic; EFWD, estimated fetal weight discordance; GA, gestational age;; 
TOP, termination of pregnancy; UCC, umbilical cord coagulation; † intracerebral injury following fetal 
demise of cotwin (case 1); ‡ selective reduction because of hemodynamic deterioration of fetus with 
iAREDF (case 2); § no ultrasound data before 27 weeks; ¶ Caesarean section because non-reassuring 
cardiotocography of fetus with iAREDF (case 3).
Comments
The flow pattern of iAREDF in monochorionic twins is best known from the classification 
system described by Gratacos et al. for selective sIUGR.7 iAREDF is caused by a large 
AA anastomosis and represents instable blood flow between both fetuses, with 
increased risk for sudden fetal demise in the smaller twin and subsequent brain 
damage in the larger twin. 
This study shows that iAREDF can also been found in MCDA pregnancies with 
appropriately grown fetuses. Only a few cases have been described in literature so far. 
We found five cases with favorable pregnancy outcome after 34 weeks of gestation 
in the literature. One is a case report16 and four were part of a larger cohort. 8 A 
large AA-anastomosis was found in all these cases, but the distance between the cord 
insertions was not reported.  Another case with iAREDF with appropriately grown 
fetuses is described in a cohort study on iAREDF in MCDA pregnancies. In this case, 
delivery took place at 29 weeks of gestation with a birth weight difference of only 2%, 
but no other details were given.17 
In our study, iAREDF was only found in cases with PCI. In the majority of PCI cases, 
iAREDF was absent or transient and pregnancy outcome was favorable. In case of 
transient abnormal flows, we hypothesize that the growth of an AA-anastomosis is 
not proportional with gestational age. The diameter of the AA-anastomoses might 
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increase less compared to the placental volume with gestational age, and the 
hemodynamic influence on the pregnancy might diminish in time. 
Sudden fetal deterioration occurred in three of the seven pregnancies with iAREDF 
in this study, suggesting a possible correlation between iAREDF, PCI and fetal 
deterioration. Although cord insertion patterns such as velamentous insertion are 
known to increase the risk of complications2,3 not much is known about the risk of 
proximate cord insertion. In monochorionic monoamniotic (MCMA) pregnancies, 
however, PCI is frequently seen.9  Unexpected fetal demise in one or both twins is 
a known risk in these pregnancies18 and is mostly attributed to cord entanglement. 
However, entanglement is not always found postnatally. Lewi et al 19 hypothesized 
that other causes such as acute exsanguination across the often present large caliber 
anastomoses between cord insertions may be an important co-factor in unexpected 
demise as well. This hypothesis could be in concordance with our findings in MCDA 
pregnancies. We did not find reports on iAREDF in appropriately grown MCMA twins. 
In PCI, monoamniotic or diamniotic, diameters of the AA anastomoses are larger and 
distance to the other twin is shorter compared to monochorionic placenta’s without 
PCI. The vascular resistance in the AA anastomosis is lower when the diameter is 
larger and the distance between the cord insertions is shorter. Therefore, systolic 
hemodynamic forces increase when distance between the cord insertions is shorter 
and the diameter of the vessel is larger. Consequently, these hemodynamic changes 
are magnified in case of unbalance, and might be responsible for sudden deterioration 
and may even result in fetal demise. In addition, when demise of the iAREDF twin 
occurs, the short anastomosis with a large diameter, with therefore a lower resistance, 
may allow a more rapid and massive exsanguination in reverse direction which can 
result in severe cerebral injury in the surviving twin as represented in case 1. 
Strengths and limitations
Our study evaluates the occurrence of iAREDF in appropriately grown MCDA 
pregnancies with PCI in a center with a high volume of MCDA pregnancies and a 
standardized follow-up, including placenta examination. A limitation of this study is 
the limited sample size, due to the low frequency of PCI in MCDA pregnancies. In 
addition, selection bias could play a role since our center is the referral center for 
monochorionic twin pregnancies in our country. MCDA with persistent abnormal 
flows are referred to our clinic for a second opinion (case 2 and 3) more often than 




Regarding management of MCDA pregnancies with PCI and iAREDF, strong conclusions 
cannot be made based on this small case series. We, however, recommend heightened 
awareness in the presence of the combination of iAREDF and PCI irrespective of fetal 
growth. We realize that such an as yet unproven concern may lead to increased 
anxiety by both parents and doctors, with the risk of (too) early interventions and 
possibly unnecessary harm of iatrogenic preterm birth. However, it is known that 
sudden fetal death occurs in up to 3.6% of appropriately grown, uncomplicated 
MCDA pregnancies after 24 weeks of gestation, and in up to 1.2% after 32 weeks 
of gestation.20-22 Some of these cases may be associated with (unrecognized) PCI 
cases with iAREDF. A large observational multicenter study is needed to evaluate the 
prevalence and pregnancy outcome of iAREDF in PCI in monochorionic pregnancies, 
before we can suggest specific management for such cases.
Conclusion
MCDA pregnancies with PCI show a higher incidence of iAREDF in the umbilical artery. 
As in sIUGR, iAREDF might be a reflection of an unstable hemodynamic balance which 
might result in adverse pregnancy outcome. Prospective studies with a larger sample 
size should be performed to evaluate this phenomenon.
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CHAPTER V
Right ventricular outflow tract 






Severe right ventricular outflow tract obstruction (RVOTO) is a potential complications 
in recipients of twin-to-twin transfusion syndrome (TTTS) that requires postnatal 
treatment. We aimed to evaluate pregnancy characteristics of neo-nates with RVOTO 
from complicated monochorionic twin pregnancies, determine the incidence of 
RVOTO in TTTS cases and construct a prediction model for its development.
Methods  
This was an observational cohort study of all complicated monochorionic twin 
pregnancies with a postnatal diagnosis of RVOTO at our center. Cases were referred 
for evaluation for evaluation because of TTTS, selective intrauterine growth restriction 
(sIUGR) or multiple congenital malformations in one of the twins. Ultrasound data 
were retrieved from our monochorionic twin database. Among liveborn TTTS 
recipients treated prenatally with laser therapy, those with RVOTO were compared 
with those without RVOTO. We describe four additional cases with RVOTO that were 
not TTTS recipients.
Results  
A total of 485  twin  pregnancies received laser therapy for TTTS. RVOTO was 
diagnosed in 3% (11/368) of liveborn TTTS recipients, of whom two showed mild 
Ebstein’s anomaly. Before laser therapy, pericardial effusion was seen in 45% (5/11) 
of RVOTO cases (P < 0.01) and abnormal A-wave in the ductus venosus (DV) in 73% 
(8/11) (P = 0.03), significantly higher proportions than in controls. Mean gestational 
age at laser therapy was 17 + 3 weeks in RVOTO cases compared with 20 + 3 weeks 
in controls (P = 0.03). A prediction model for RVOTO was constructed incorporating 
these three significant variables. One TTTS donor had RVOTO after transient hydrops 
following laser therapy. Three larger twins in sIUGR pregnancies developed RVOTO, 
the onset of which was detectable early in the second trimester.
Conclusion  
RVOTO occurs in TTTS recipient  twins  but can also develop in TTTS donors and 
larger twins of pregnancies complicated by sIUGR. Abnormal flow in the DV, pericardial 
effusion and early gestational age at onset of TTTS are predictors of RVOTO in TTTS 
recipients, which suggests increased vulnerability to hemodynamic imbalances in 
the fetal heart in early pregnancy. These findings could guide diagnostic follow-up 
protocols after TTTS treatment. 




Severe right ventricular outflow tract obstruction (RVOTO) is a heart anomaly that 
requires surgery or catheter intervention in the newborn period or early infancy.1,2 
Fetal RVOTO is being diagnosed increasingly in complicated monochorionic twin 
pregnancies, and usually starts with right ventricular hypertrophy leading to valvular, 
subvalvular or supravalvular outflow tract obstruction, including pulmonary valve 
stenosis and pulmonary atresia. Severe postnatal RVOTO is reported mainly in 
recipients of twin-to-twin transfusion syndrome (TTTS),3,4 although it has been 
reported sporadically in TTTS donors and in the larger twin of a monochorionic pair 
with selective intrauterine growth restriction (sIUGR).2,5-7
Right ventricular hypertrophy and RVOTO may be present in recipients at the time 
of diagnosis of TTTS or can develop later in pregnancy. RVOTO can be transient, 
progressive or persistent, even beyond the neonatal period.8 The reported incidence 
of severe RVOTO in liveborn recipients varies between 2% and 8%, but the true 
incidence is difficult to estimate.2,4,5,9 Laser intervention at an early stage of TTTS is 
associated with a significant reduction in the incidence of RVOTO.4,10,11 Risk factors for 
the development of RVOTO are unknown.
The objective of this study was to evaluate pregnancy characteristics of neonates from 
a complicated monochorionic twin pregnancy with clinical signs of RVOTO. We aimed 
to determine the incidence of RVOTO in TTTS cases and construct a prediction model 
for its development. Identification of these risk factors may guide further follow-up 





The Leiden University Medical Center is the national referral center for fetal therapy 
in The Netherlands. Twin pregnancies complicated by TTTS are referred to our center 
for fetoscopic laser coagulation of placental anastomoses. Monochorionic twin 
pregnancies with sIUGR or with discordance for multiple congenital abnormalities 
(MCA) are referred if selective feticide of the affected twin is considered by the 
parents. All data on sonographic findings, operative characteristics and neonatal 
outcomes in complicated monochorionic twin pregnancies are entered prospectively 
in a database. All monochorionic twin pregnancies referred to or treated in our center 
between January 2004 and July 2015 were reviewed for a postpartum diagnosis of 
RVOTO.
The diagnosis of RVOTO was made by postnatal echocardiography. The scan was 
indicated by clinical signs of RVOTO or because prenatal scans showed cardiac 
abnormalities. All twins were seen at our follow-up clinic at the age of 2 years, at 
which time hospital admissions and interventions were noted. In this cohort of 
monochorionic twins there is a 3% lost-to-follow-up rate at this visit.
RVOTO was defined as subvalvular, valvular or supravalvular pulmonary stenosis (PS) 
or pulmonary atresia on postnatal echocardiography, with or without the presence 
of tricuspid regurgitation. PS was defined as an elevated peak velocity over the 
pulmonary valve, classified as mild (2–3 m/s), moderate (3–4 m/s) or severe (> 4 m/s).12
TTTS was diagnosed using the Eurofoetus criteria,13 i.e. polyuric polyhydramnios in the 
recipient twin with a deepest vertical pocket (DVP) of 8 cm before 20 weeks’ gestation 
and 10 cm after 20 weeks, and oliguric oligohydramnios in the donor twin with a DVP 
of < 2 cm. The Quintero staging system was used to classify the severity of TTTS.14 
Pericardial effusion was defined as the accumulation of pericardial fluid of > 2 mm 
at the level of the atrioventricular valves.15 Hydrops was defined as the accumulation 
of fluid in two or more compartments (skin, ascites, pleural effusion or pericardial 
effusion) of the fetal body. All TTTS cases were treated by laser coagulopathy.
Laser surgery was offered to cases with Quintero Stage II or higher, or Stage I with 
symptomatic polyhydramnios. A preoperative ultrasound examination was performed 
in all cases to diagnose and stage TTTS. The findings of this examination were used 
to identify parameters as predictors for postnatal RVOTO in TTTS recipients. All 
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fetuses underwent a full echocardiographic examination, but extended assessment 
of fetal cardiac function was not routinely performed in the earlier years of this study. 
The size of the aorta and pulmonary artery were measured if they appeared to be 
abnormal. Signs of fetal cardiac adaptation or compromise were evaluated. Intertwin 
discordance in estimated fetal weight (EFW) was calculated as ((recipient EFW – donor 
EFW)/ recipient EFW) × 100. Abnormal flow in the ductus venosus (DV) was defined 
as an absent or reversed A-wave. Cardiomegaly was defined as a cardiothoracic ratio 
greater than the 95th percentile for gestational age, measured in a transverse plane 
of the fetal thorax at the level of the four-chamber view of the fetal heart and in 
diastole.16,17 Tricuspid regurgitation was defined as visualization of a clear jet across 
the tricuspid valve in systole, using color Doppler ultrasound in an apical four-chamber 
view. Laser coagulation of the vascular anastomoses was performed as described 
previously.18 The first ultrasound examination after laser coagulation was performed 
from 24 h to approximately 1 week after the procedure. Further follow-up scans were 
scheduled at least biweekly for all patients until birth.
sIUGR was defined as an EFW < 10th percentile in one twin and an intertwin difference 
of > 25% in the absence of TTTS. sIUGR was classified into three types according 
to Gratacós et al.19 In Type I, the smaller twin has positive end-diastolic flow in the 
umbilical artery, in Type II it has persistently absent or reversed end-diastolic flow and 
in Type III it has intermittently absent or reversed end-diastolic flow.
Statistical analysis
Statistical analysis was performed with IBM SPSS 20.0 statistical package (IBM Corp., 
Chicago, IL, USA). TTTS recipients with clinical symptoms of RVOTO were compared 
with recipients without RVOTO, which were used as controls. A multivariable logistic 
regression model was constructed using stepwise backward elimination to identify 
independent predictors for the development of RVOTO in TTTS recipients to include 
in a final prediction model. All variables with P < 0.05 were considered risk factors and 
odds ratios (ORs) including 95% CIs were computed. The area under the receiver–
operating characteristics (ROC) curve was calculated to assess the ability of the model 





Fifteen neonates from monochorionic twin pregnancies diagnosed postnatally 
with RVOTO were identified in our database. Two cases were cotwins in a single 
pregnancy, thus 14 pregnancies were analyzed. Ultrasound findings at the time of 
laser therapy and postnatal diagnosis and interventions are summarized in Tables 1 
and 2, respectively.
TTTS recipients
During the study period, 485 twin pregnancies received laser therapy for TTTS. 
RVOTO was diagnosed in 11 (3%) of the 368 liveborn recipients available for follow up. 
Pregnancy and ultrasound characteristics of this group at the time of laser therapy are 
shown in Table 3 and compared with all liveborn recipients without RVOTO (controls). 
The mean gestational age at diagnosis and treatment of TTTS in RVOTO cases was 
17 + 3 weeks, significantly lower than in the control group (20 + 3 weeks; P = 0.004). 
Abnormal flow in the DV (P < 0.01), pericardial effusion (P < 0.01) and ascites (P = 0.03) 
at the time of diagnosis of TTTS occurred significantly more frequently in the RVOTO 
cases than in controls.
Variables found to be independent predictors for RVOTO were gestational age at 
diagnosis (OR, 0.96 (95% CI, 0.92–0.996)), abnormal flow in the DV (OR, 5.13 (95% 
CI, 1.15–22.96)) and pericardial effusion (OR, 26.1 (95% CI, 4.9–139)). A prediction 
model for the risk of RVOTO at birth in TTTS recipients was constructed, incorporating 
gestational age, presence of abnormal flow in the DV and presence of pericardial 
effusion (Table 4). In cases with TTTS diagnosed at 15 weeks’ gestation, the risk for 
RVOTO was > 80% when both pericardial effusion and abnormal DV flow were present. 
The risk decreased to 11% if these signs were present but TTTS was diagnosed after 
26 weeks. With normal flow in the DV and an absence of pericardial effusion, the 
risk for RVOTO was 4% in cases with TTTS diagnosed at 15 weeks and 0% in cases 
diagnosed at or after 22 weeks. The area under the ROC curve of the prediction 
model was 0.92 (95% CI, 0.88–0.98) (Figure 1).
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Table 3. Characteristics at time of laser therapy for twin-to-twin transfusion syndrome (TTTS) 
in recipients with postnatal diagnosis of right ventricular outflow tract obstruction (RVOTO) and 







P-value OR (95% CI) P-value
GA at laser therapy 
(weeks)






9 (81.8) 153 (42.9) 0.07
Abnormal DV flow 8 (72.7) 66 (19.7)† < 0.01 5.13 (1.15–22.96) 0.03
Ascites 2 (18.2) 7 (2.0) 0.03 0.33
Skin edema 1 (9.1) 3 (0.8) 0.11
Pleural effusion 0 (0) 2 (0.6) 0.94
Cardiac compromise
Cardiomegaly 4 (36.4) 102 (29.7)† 0.22
Tricuspid insufficiency 2 (18.2) 42 (14.2)† 0.27
Pericardial effusion* 5 (45.5) 8 (2.2) < 0.01 26.1 (4.9–139) < 0.01
Data are given as n (%) or mean ± SD.  
*Isolated pericardial effusion found in 3/5 RVOTO cases and 4/8 controls.  
†Missing data: abnormal DV flow (6%), cardiomegaly (3.8%), tricuspid insufficiency (17%).  
DV, ductus venosus; EFW, estimated fetal weight; GA, gestational age; OR, odds 
◀Figure 1. Receiver–operating 
characteristics (ROC) curve for 
prediction of right ventricular 
outflow tract obstruction at 
birth in recipient twin of twin-
to-twin transfusion syndrome 
(TTTS) using model incor-
porating gestational age at 
diagnosis of TTTS and presence 
of pericardial effusion and 
abnormal flow in the ductus 




Table 4 shows a risk estimation for RVOTO for each week of gestation at which TTTS 
is diagnosed. This risk is stratified according to the presence or absence of abnormal 
flow in ductus venosus or the presence of pericardial effusion. Example: if TTTS is 
diagnosed at 15 weeks with normal DV and absent PE, risk for neonatal PS is 4%.
Table 4. Prediction model: predicted risk for RVOTO at birth for recipients
GA diagnosis of 
TTTS
(weeks)
PE absent PE present
Normal DV Abnormal DV Normal DV
 
Abnormal DV 
15 4 20 43 82
16 3 16 35 77
17 2 12 28 70
18 2 9 22 63
19 1 6 17 55
20 1 5 13 47
21 1 3 10 39
22 0 3 7 31
23 0 2 5 25
24 0 1 4 19
25 0 1 3 14
26 0 1 2 11
Data are given as percentage risk
TTTS donors and sIUGR
Four fetuses diagnosed with RVOTO were not TTTS recipients; one was the donor 
twin in a TTTS pregnancy and three were the larger twins in sIUGR pregnancies. 
Because pregnancies with sIUGR are referred to our center only if selective feticide is 
considered, the incidence of RVOTO in this group could not be deduced. Because of 
the limited sample size, statistical analysis of risk factors was not performed.
The TTTS donor with RVOTO and the recipient cotwin were concordant for RVOTO. 
At the time of diagnosis of TTTS (19 + 6 weeks), the recipient twin showed signs of 
RVOTO, while signs of cardiac compromise were absent in the donor twin. After 
the laser procedure, the donor twin developed transient hydrops with massive skin 
edema, pleural effusion and mild ascites. The hydrops resolved, but the donor twin 
showed progressive RVOTO up to birth.
In the sIUGR pregnancies with RVOTO in the larger twin, two were complicated by 
MCA in the smaller twin, and umbilical cord coagulation was performed in both cases 
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(Table 1). Both larger twins showed pericardial effusion at the time of the intervention; 
one case had elevated peak systolic velocity in the pulmonary artery and in the other 
case cardiomegaly was present. Both fetuses developed progressive RVOTO in the 
subsequent weeks following the intervention. In the third sIUGR case, no abnormality 
was seen in the smaller twin and umbilical cord coagulation was not performed. 
Intermittent absent/reversed end-diastolic flow in the umbilical artery was present 
in the smaller twin, staged as sIUGR Type III according to Gratacós et al.19 Pericardial 
effusion was seen from 17 weeks onwards in the larger twin, which developed severe 
pulmonary stenosis. This case has been reported previously by our group.20
Neonatal outcome
Details of postnatal diagnosis and treatment of all 15 cases with RVOTO are summarized 
in Table 2. Two (13%) of the neonates died within 1 week owing to prematurity and 
sepsis combined with cardiac failure before cardiac intervention could be performed. 
Eleven (73%) cases received surgical or catheter-based intervention within the first 
postnatal months. In two cases, Ebstein’s anomaly was diagnosed, with true inferior 
displacement of the valve. In both cases the anomaly was mild, with normal right 
ventricular function. In one (7%) case, pulmonary stenosis was not detected prenatally 
(Case 3). This case was referred early in the study period and only absent A-wave 
in the DV was present at the time of laser therapy. At follow-up, cardiomegaly was 
noted, but detailed echocardiography was hampered by blurred imaging because of 
maternal obesity and preterm rupture of membranes.
Discussion
This study shows that an early gestational age at diagnosis of TTTS, abnormal flow 
in the DV and pericardial effusion are predictors of the development of RVOTO. 
Our prediction model shows that the risk of development of RVOTO is highest in 
the presence of abnormal DV flow and pericardial effusion when TTTS is diagnosed 
early in the second trimester; the risk decreases with increasing gestational age at the 
diagnosis of TTTS.
The association of RVOTO with an early gestational age at TTTS diagnosis was 
suggested previously in a case report20 and is confirmed in this regional cohort of 
consecutive cases. The cascade of cardiac adaptations in TTTS, in which volume loading 
and ventricular hypertrophy with tricuspid regurgitation occur in the recipient, is well 
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known.3,21,22 The hypertrophy leads to a stiff, non-compliant ventricle with impaired 
diastolic function. The cardiovascular score of TTTS described by Rychik  et al.22 
incorporates cardiovascular parameters as a reflection of the severity of the disease. 
In this study, decreased size of the pulmonary artery was found in TTTS recipients. 
This finding was attributed to diminished forward flow across the valve. Intracardiac 
circulation is necessary for cardiac morphogenesis and vasculogenesis.23,24 In the 
absence of sufficient forward flow due to abnormal right ventricular function in TTTS, 
the pulmonary valve might fail to grow. If the TTTS remains untreated, this process 
could lead to the development of PS or pulmonary atresia.
Early in the second trimester semilunar valve maturation is not complete,25 and we 
hypothesize that, in this period, the fetal heart is therefore more susceptible to 
hemodynamic imbalances leading to RVOTO. This explains our finding that postnatal, 
and thus persistent, RVOTO is associated with an early gestational age at diagnosis of 
TTTS. It is plausible that temporary RVOTO, more often seen later in pregnancy, may 
represent obstruction due to myocardial hypertrophy in TTTS that disappears with 
normalization of the myocardium after laser treatment, without anatomical stenosis 
of the pulmonary valve.
The finding that abnormal tricuspid valve development can occur in TTTS is new. A 
recent study in zebrafish showed that prolonged disturbance in intracardiac flow 
during the period of embryogenesis resulted in abnormal development of the 
atrioventricular valve.26 Abnormal intracardiac flow, as seen in TTTS, might result in 
malformation of the tricuspid valve and right ventricle, as seen in Ebstein’s anomaly.22,27
The other two parameters in the prediction model for RVOTO are a reflection of 
the severity of cardiac compromise in the late stages of TTTS. These parameters 
confirm the presence of altered hemodynamics, as in the above-described cascade 
of events. Laser therapy often improves cardiac function through restoration of the 
hemodynamic imbalance,10,11,17,20,28 and the majority of fetuses will recover without 
developing RVOTO.11,29 If hydrops is present, up to one third of fetuses develop 
cardiac abnormalities such as RVOTO.30 Timely diagnosis and laser treatment might 
contribute to a better cardiac outcome in TTTS.
Although our prediction model needs further validation, it could be an aid to antenatal 
and postnatal follow-up. When pericardial effusion or abnormal DV flow is present, 
especially when TTTS occurs early in pregnancy, we recommend echocardiographic 
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follow-up in a specialized center, and additional postnatal follow-up is necessary 
to detect cases with mild RVOTO. In our opinion, it is too early to recommend 
refraining from echocardiographic follow-up examinations in low-risk pregnancies. 
The possibility of delivering in centers with pediatric cardiology services in TTTS cases 
without prenatal signs of RVOTO depends on healthcare systems and travel distances, 
and individual cases should be treated according to local circumstances.
For the larger twin in sIUGR pregnancies, risk factors for RVOTO could not be 
evaluated because our cohort was influenced by referral bias. However, in all three 
pregnancies with RVOTO and one previously described case,6,7 sIUGR was already 
evident early in the second trimester, which is in accordance with our findings in 
TTTS cases. All cases had signs of cardiac compromise in the second trimester, 
thus suggesting a developmental pathway similar to that seen in TTTS cases. The 
pattern of vascular anastomoses in sIUGR is usually different from that in TTTS. In 
up to 98% of sIUGR cases, a large arterioarterial anastomosis is present.31 These 
anastomoses are thought to cause an unstable hemodynamic balance, especially if 
flow recordings show sIUGR Stage III according to Gratacós et al.19,32 We speculate 
that large arterioarterial anastomoses in the early stages of pregnancy also cause 
disturbances in intracardiac flow. The hypertrophic cardiomyopathy-like changes that 
have been found in cases with large arterioarterial anastomoses support the theory 
of altered intracardiac hemodynamics.33
Finally, this large, consecutive cohort of TTTS cases has established an incidence of 
RVOTO of 3% in recipient twins.4,9 Higher incidences have been reported previously, but 
may be explained by a limited number of cases5,10 or by the studies being performed 
prior to routine laser therapy and therefore representing untreated TTTS.21
The strength of this study is the large consecutive cohort of TTTS cases, which allowed 
us to analyse the incidence and risk factors for RVOTO and enabled us to develop a 
prediction model. Prospective validation should be performed to assess the value 
of the prediction model, especially because the sample size was limited. Another 
limitation is the retrospective approach of prospectively collected data. We used 
items of the TTTS Quintero staging system to identify clinically relevant predictors 
of RVOTO. Extended prenatal and postnatal echocardiographic follow-up was not 
performed systematically in all survivors in the early years of the study period, and it 
is therefore possible that cases with mild RVOTO were missed.
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 In the prediction model, one recipient was concordant with the donor for pulmonary 
stenosis. Although a genetic component could be suggested in this case, we included 
this recipient in the statistical analysis. We believe that hemodynamic disturbances 
were a probable cause of RVOTO in both fetuses, as RVOTO was already present in 
the recipient at the time of diagnosis of TTTS and the donor developed RVOTO after 
a transient period of hydrops directly following laser therapy.
Conclusion
RVOTO in monochorionic twins occurs not only in recipients but also in donors and 
larger twins of pregnancies with sIUGR. In cases with TTTS, the fetal heart is more 
vulnerable to the development of RVOTO in early pregnancy. When abnormal flow 
in the DV and pericardial effusion are present, accurate prenatal and postnatal 
sonographic follow-up is mandatory.
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CHAPTER VI
Acquired right ventricular outflow  
tract obstruction in twin-to-twin  
transfusion syndrome;  





The pathophysiology of right ventricular outflow tract obstruction (RVOTO) in twin-to-
twin transfusion syndrome (TTTS) recipients is incompletely understood. We aimed to 
investigate the development and spectrum of RVOTO in TTTS recipients.
Methods  
A prospective longitudinal cohort study was conducted between 2015 and 2017. 
Echocardiographic assessment was performed in recipients from TTTS diagnosis until 
the neonatal period.
Results  
Prenatal RVOTO, defined as abnormal flow velocity waveforms across the pulmonary 
valve (PV), was diagnosed in 12.9% (16/124) of recipients at TTTS diagnosis. Postnatal 
RVOTO was found in 6.7% (7/105) of surviving recipients. All recipients with severe 
postnatal RVOTO showed prenatal RVOTO at TTTS diagnosis. In 5.6% (6/108) of 
cases, prenatal RVOTO appeared only after laser therapy, and in 1.9% (2/108), this 
progressed to mild postnatal pulmonary stenosis. Elevated peak systolic PV velocities 
were more frequently associated with postnatal RVOTO compared with prenatal 
finding of functional pulmonary atresia. Postnatal RVOTO was associated with early 
manifestation of TTTS but was equally found in all Quintero stages.
Conclusion  
In the spectrum of postnatal RVOTO, severe cases show prenatal RVOTO at TTTS 
diagnosis. However, RVOTO can develop after laser or even in the neonatal period 
and in all Quintero stages. A potential risk factor for postnatal RVOTO is early TTTS 
manifestation.




Right ventricular outflow tract obstruction (RVOTO) is a relatively common finding 
in recipients in twin-to-twin transfusion syndrome (TTTS). In untreated TTTS, 
approximately 10% to 12% of recipients will develop congenital heart disease, 
including RVOTO.1, 2 Fetoscopic laser therapy is known to improve cardiac function, 
and the reported incidence of postnatal RVOTO in surviving recipients after laser 
therapy is 2% to 3% in larger series.3-7
The pathophysiology of RVOTO in TTTS is not fully understood, and risk factors 
for progression to postnatal RVOTO are still difficult to determine. Most studies 
focus on preintervention assessment of RVOTO, because systematic longitudinal 
echocardiographic follow-up of all recipients after laser therapy is difficult to establish 
in fetal therapy centers.4, 5, 8-11 This impedes knowledge on the complete spectrum 
of RVOTO.12   Furthermore, the true incidence of RVOTO might be underestimated, 
because of undetected late-onset or mild cases.
The aim of this study was to investigate the incidence and the spectrum of RVOTO 
in all recipients from the onset of TTTS. We followed all cases throughout pregnancy 
until delivery and performed a systematic assessment in the neonatal period, to 
contribute to the understanding of pathophysiology of RVOTO development.
Methods
A prospective cohort study was performed between January 2015 and March 2017. All 
consecutive monochorionic pregnancies referred to our center for TTTS in this period 
were included in this study. The Leiden University Medical Center is the national 
referral center for fetal therapy in the Netherlands. A comprehensive preoperative 
ultrasound examination was performed in all cases to stage TTTS. The severity of 
TTTS was classified according to the Quintero staging system.13  Laser therapy was 
performed in stage 2 or higher or in stage 1 if severe maternal discomfort or cervical 
shortening was present. Reasons not to perform laser therapy were advanced cervical 
dilatation or a gestational age greater than 28 weeks.
Following laser therapy, patients remained in hospital for 12 to 24 hours. An ultrasound 
examination was performed within 24 hours and approximately 1 to 2 weeks after 
laser therapy. After that, at least monthly follow-up scans were performed until birth 
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at our department. In case of the absence of other complications, induction of labor 
was initiated at 36 weeks of gestation.
Extended fetal echocardiography was performed in all examinations, using an Aplio 
500 (Toshiba Medical System Corporation, Otawara-Shi, Tochigi, Japan). We assessed 
the right ventricular outflow tract with a recording of the flow velocity waveform across 
the pulmonary valve (FVW-PV). The sample volume was placed distal to the valve, with 
an insonation angle of less than 20°. Measurements were made in absence of fetal 
breathing movements. Normal FVW-PV was defined as forward flow across the valve 
with a peak systolic velocity less than 1 m/s. Prenatal RVOTO was defined as abnormal 
FVW-PV, and three subgroups were identified as described before.4  Functional 
pulmonary atresia was defined as the absence of forward flow across the pulmonary 
valve with an exclusive reverse direction of flow in the ductus arteriosus. Pulmonary 
stenosis was defined as turbulent flow with a peak systolic velocity of greater than 
1 m/s, whether or not across a thickened or echogenic pulmonary valve and whether 
or not combined with insufficiency across the pulmonary valve. Isolated pulmonary 
insufficiency was defined as pulmonary insufficiency with reversed flow from main 
pulmonary artery entering the right ventricle, with either forward or bidirectional flow 
in the ductus arteriosus, in the absence of other signs of RVOTO.4 The flow across the 
atrioventricular valves was assessed with color Doppler and categorized according 
to duration of the jet during the cardiac cycle.14 Atrioventricular valvular insufficiency 
was categorized as mild if the jet appeared only early systolic, moderate if it appeared 
early to midsystolic and severe if the jet appeared throughout the complete systole. 
Diastolic function was assessed by analysis of the pulsed wave Doppler tracings of 
ductus venosus and umbilical vein. Abnormal ductus venosus FVW was defined as 
an absent or reversed A-wave. Pulsatile flow across the umbilical vein was defined as 
abnormal.
Postnatal assessment composed of a transthoracic echocardiogram in the first week 
of life and a second echocardiogram 1 month after the estimated date of delivery. A 
Vivid E9 or S6 (GE Healthcare, Wauwatosa, Wisconsin) echo machine was used for 
postnatal echocardiography. Peak velocity across the pulmonary valve was measured 
by continuous wave Doppler in the short axis view. Postnatal pulmonary stenosis and 
pulmonary atresia were both categorized as postnatal RVOTO. Pulmonary stenosis in 
neonates was defined as mild when the peak gradient was 2 to 3 m/s, moderate when 
the peak gradient was 3 to 4 m/s, and severe when the peak gradient was greater than 
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4 m/s. Clinical data were requested if cases were delivered in referring hospitals. To 
retrieve optimal follow-up, we contacted mothers that were not able to attend follow-
up visits about 2 months after the estimated date of delivery and asked for hospital 
admission or treatment for RVOTO in their infant(s) in other centers. The study was 
approved by the medical ethical committee of the Leiden University Medical Center. 
All mothers signed informed consent.
Statistical analysis
Statistical analysis was performed with IBM SPSS 20.0 statistical package (Chicago, 
Illinois). Categorical variables were analysed by mixed model analysis and continuous 
variables with independent samples t-test. A p-value of less than 0.05 was considered 
statistical significant.
Results
In the study period, 124 pregnancies were referred for TTTS to our center, 119 were 
monochorionic diamniotic (MCDA) twins and five were monochorionic triamnionic or 
dichorionic triamniotic triplets. Laser therapy was performed in 115 cases, nine cases 
were managed expectantly because of Quintero stage 1 (n = 5), stage 5 (n = 2), or 
advanced gestational age (n = 2). Figure 1 summarizes the incidence of prenatal and 
postnatal RVOTO from TTTS diagnosis until the neonatal period, and Table 1 shows 
the baseline characteristics of prenatal and postnatal RVOTO cases. 




Table 1. Baseline characteristics of recipients with abnormal FVW‐PV at TTTS and postnatal 
RVOTO









GA at TTTS diag-
nosis †



























Laser performed 96 (88.9%) 13 (81.3%) 91 (92.9%) 5 (71.4%)
Fetal demise 16 (14.8%) 3 (18.8%)
GA at delivery† 33+2 (6+1) 34+3 (3+2)
Values given as †median (IQR), or ‡number (%). *p-value 0.19, ** p-value is 0.03 FVW-PV, 
flow velocity waveforms of the pulmonary valve; TTTS, twin-to-twin transfusion syndrome; 
RVOTO, right ventricular outflow tract obstruction; GA, gestational age
All 124 pregnancies received extended echocardiography at time of TTTS diagnosis. 
In 12.9% (16/124) of the recipients, prenatal RVOTO was present at the time of the 
TTTS diagnosis. Isolated pulmonary insufficiency was seen in seven cases (Table 2), 
pulmonary atresia (PA) in four cases (Table 3), and pulmonary stenosis in five cases 
(Table 4). 
Table 2. Echocardiographic findings in recipients with isolated pulmonary insufficiency at time 
of TTTS diagnosis




UV birth Postnatal 
findings
1 III 19+3 yes mild no reverse pulsatile 37+2 normal
2 III 15+6 yes mild no reverse pulsatile †
3 III 17+2 Yes no no reverse pulsatile 29+3 normal
4§ III 22+4 yes severe no reverse pulsatile 35+6 normal
5 II 16+5 yes mild no normal pulsatile 28+0 normal
6§ III 21+2 yes severe no reverse pulsatile ‡
7 III 16+3 yes no no normal pulsatile †
TTTS, twin-to-twin transfusion syndrome; Q, Quintero stage; GA, gestational age; TI, tricuspid 
insufficiency; MI, mitral insufficiency; DV, ductus venosus A-wave; VU, umbilical vene; CTR, cor-thorax 
ratio § cases with circular shunt physiology; †immature birth; ‡fetal demise
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GA Laser TI MI A-wave
DV
UV birth Postnatal 
Diagnosis and 
follow up
8 IV 16+5 yes severe no reverse pulsatile 34+3 Severe PS, severe TI 
with right ventricle 
dilatation, NND 
<1wk (cardiac fail-
ure combined with 
sepsis)
9 III 25+1 yes no 
inflow/
outflow
no reverse pulsatile 30+5 Normal, A&W
10 III 23+6 yes severe no reverse Pulsatile 26+6 Normal, A&W
11 III 24+1 yes severe no reverse - 28+1 Mild PS, A&W
TTTS, twin-to-twin transfusion syndrome; Q, Quintero stage; GA, gestational age; TI, tricuspid 
insufficiency; MI, mitral insufficiency; DV, ductus venosus; UV, umbilical vene; PS, pulmonary stenosis;  
NND, neonatal death; A&W, alive and well
Prenatal RVOTO improved in nine out of 16 cases after laser therapy. In four cases, 
prenatal RVOTO was persistent or progressive until the neonatal period, of which 
three were in the pulmonary stenosis group. Two of these cases were in Quintero 
stage 1 and were managed expectantly. None of the cases with isolated pulmonary 
insufficiency developed postnatal RVOTO. Fetal demise in the prenatal RVOTO group 
occurred in three out of 16 cases, two because of birth before 24 weeks of gestation 
and one intrauterine demise occurred 2  weeks after laser therapy in a fetus with 
isolated pulmonary insufficiency and persistent severe TI.
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GA Laser TI MI A-wave
DV
UV birth Postnatal 
diagnosis and 
follow up




13 III 1.2 m/s 16+4 yes mild no reverse Normal 35+3 Normal,
 A&W








16 I 1.5m/s 28+5 no severe no normal Normal 34+1 Normal, 
A&W
TTTS, twin-to-twin transfusion syndrome; Q, Quintero stage; PV, pulmonary valve; GA, gestational age 
at TTTS diagnosis; TI, tricuspid insufficiency; MI, mitral insufficiency; DV, ductus venosus; UV, umbilical 
vene; PS, pulmonary stenosis; PA, pulmonary atresia; A&W, alive and well 
All cases received longitudinal follow-up during pregnancy. In 87% (108/124) of 
recipients, signs of prenatal RVOTO were absent at TTTS diagnosis. In 4.8% (6/124), 
prenatal RVOTO was observed only after laser therapy; these cases are summarized 
in Figure 2. In three cases, prenatal RVOTO was observed in the first examination 
within 24  hours after uncomplicated laser therapy. These three cases showed 
completely normal FVW-PV in the subsequent ultrasound examination 1 week after 
laser therapy. In three other cases, prenatal RVOTO appeared several weeks after 
laser therapy. Two of these cases were diagnosed with pulmonary stenosis in the 
neonatal period; the other developed primary pulmonary hypertension (PPHN).
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FVW-PV, flow velocity waveforms across the pulmonary valve; TI, tricuspid insufficiency; PI, pulmonary 
insufficiency; PA, pulmonary atresia; IUD, intrauterine demise; RVH, right ventricle hypertrophy; PPHN, 
persistent pulmonary hypertension of the neonate; RVOTO, right ventricular outflow tract obstruction
Postnatal echocardiographic follow-up was performed in 67.6% (71/105) of surviving 
recipients. In 43% (45/105), follow-up was performed within the first week of life, and 
in 61% (64/105), follow-up was performed 1 month after estimated date of delivery. In 
cases without a postnatal scan, cancellation of the appointment was requested by the 
parents due to logistic reasons. The majority of these cases were pregnancies with 
uncomplicated recovery after TTTS. In these cases, delivery took place in the referral 
centers with long travel distance. In all the cases, mothers were interviewed about the 
details of the hospital admissions and possible cardiac examinations of the infants. In 
none of them cardiac anomalies were diagnosed.
Postnatal RVOTO was diagnosed in 6.7% (7/105) of the surviving recipients, of which 
2.9% (3/105) were severe. Of the three severe cases, one was born at 34 weeks of 
gestation and died within the first week of life due to cardiac failure combined with 
sepsis. Two other neonates needed balloon valvuloplasty within the first month of life. 
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All severe cases showed RVOTO prenatally; the first case showed pulmonary atresia 
at TTTS diagnosis; the two others showed pulmonary stenosis. In one case (0.9%), 
mild pulmonary stenosis was observed at the second scan at the age of 2 months, 
whereas no signs of RVOTO were seen prenatally or at the first postnatal scan after 
delivery at 36 weeks of gestation.
The mean gestational age at TTTS diagnosis was 17 + 4 weeks in surviving recipients 
with postnatal RVOTO compared with 19 + 1 weeks in those without postnatal RVOTO, 
which is significantly lower (P  = 0.03). Of 115 lasers, 43 were performed less than 
18 weeks of gestation, of which five developed postnatal RVOTO (11.6%), 65 were 
performed between 18 and 24 weeks of gestation of which two developed postnatal 
RVOTO (3.1%), and 17 were performed after 24  weeks in which none developed 
postnatal RVOTO. The gestational age at TTTS diagnosis did not differ between 
recipients with and without prenatal RVOTO (P = 0.19). Quintero stages were equally 
distributed in cases with postnatal RVOTO, while prenatal RVOTO at TTTS diagnosis 
seem to occur more in the advanced Quintero stages (Table 1).
Comments
The incidence of prenatal RVOTO in this prospective, consecutive cohort is 12.9% 
in recipients at TTTS diagnosis, of which 4/16 (25%) showed PA, 5/16 (31%) showed 
PS, and 7/16 (44%) showed isolated PI. Postnatal RVOTO was diagnosed in 6.7% of 
surviving recipients. All severe postnatal cases (2.9%) showed prenatal RVOTO at the 
time of TTTS diagnosis, while the majority of the mild postnatal RVOTO cases became 
apparent weeks after laser therapy or even in the neonatal period. A new finding is 
the occurrence of postnatal RVOTO in TTTS Quintero stage 1 cases, with expectant 
management.
Our results correspond well to previous prevalence estimates of prenatal RVOTO 
before laser therapy. Michelfelder et al4  reported a prevalence of 8.7% in a 
retrospective cohort, of which 45% showed PA, 30% PS, and 25% isolated PI. Moon-
Grady et al9 reported 21% of abnormal pulmonary valve function before laser therapy 
in a retrospective cohort, of which 25% showed PA, 62% PS, and 17% showed 
pulmonary insufficiency (PI). In a retrospective study of cardiac function in stage 4 
TTTS by van Mieghem et al,15 preoperative PA was found in 36% of recipients.
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In the current study, pulmonary stenosis or atresia at the time of TTTS diagnosis 
resulted in severe postnatal valvular stenosis in 33% of cases (3/9) and in mild stenosis 
in 11% (1/9).4, 8-10 In addition, 2% of cases with initial normal FVW-PV at TTTS diagnosis 
developed abnormal FVW-PV in the weeks after laser therapy, which progressed to 
mild valvular stenosis in the neonatal period.
Because most studies on this topic focus on recipients with preintervention RVOTO and 
lack longitudinal prospective follow-up on all recipients, detection of these late-onset 
cases is rarely described before.1  Initial mild RVOTO after birth is however important, 
as it may progress to severe RVOTO with need for intervention in infancy.1, 16 The total 
incidence of postnatal RVOTO found in this study is slightly higher than in prior large 
cohort studies, which found an incidence of 2.1% to 4%.3-5, 17 This can be explained 
by the systematic longitudinal follow-up of all recipients in pregnancy, which allowed 
us to detect mild and late-onset cases. However, the total incidence in this study 
is possibly underestimated because postnatal echocardiographic assessment was 
performed in only 67.6% (71/105) of surviving recipients, and for that, mild cases 
could have been missed, because cases without a postnatal scan were regarded as 
no postnatal RVOTO, because of the absence of clinical signs of RVOTO.
Several pathways of RVOTO development have been suggested, such as the 
underdevelopment of the pulmonary valve due to decreased forward flow across 
the PV, caused by right ventricular hypertrophy, the effect of endothelial damage 
caused by shear stress, which eventually results in valve dysplasia and damage of 
the valve due to exposure to abnormal concentrations of vasoactive mediators 
such as endothelin-1, renin, and angiotensin II.16,  18-22  The decreased flow across 
the PV may be explained by impaired cardiac function at the time of TTTS.2, 6, 7, 23-
25  Myocardial hypertrophy combined with increased systemic afterload can result 
in insufficient closure of the valve, which ultimately causes pulmonary insufficiency 
and eventually bidirectional flow in the ductus arteriosus, which was categorized 
as isolated pulmonary insufficiency.4 With progression of the TTTS, cardiac function 
worsens, and the FVWs across the PV develop to functional pulmonary atresia with 
no right ventricular outflow. After laser therapy, volume overload and cardiac function 
are restored, and the FVW-PV will normalize, in the absence of irreversible anatomical 
changes to the pulmonary valve. Accordingly, isolated pulmonary insufficiency may 
be considered as a relatively mild finding in TTTS, which is presumably reversible 
after laser therapy. This hypothesis is supported by the observation that none of 
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these cases in our series did develop postnatal RVOTO, confirming the finding in a 
retrospective cohort study by Michelfelder et al.4
In contrast to this, cases with pulmonary insufficiency with reversed circular shunt 
physiology were included in the isolated PI in our cohort (cases 4 and 6, Table 2). 
Circular shunt physiology is a circular shunt in which blood originating in one cardiac 
chamber is shunted through the heart to return to the original chamber without 
ever crossing a capillary bed and described in recipients in a recent study of Pruetz 
et al.11  In one case, fetal demise occurred, while the other case improved without 
echocardiographic abnormalities postnatally in this recipient. Pruetz et al stated 
that recipients with preoperative circular shunt physiology are at increased risk for 
postnatal right ventricular outflow tract obstruction. Our sample size is, however, too 
small to conclude this.
All prenatal pulmonary atresia cases in our study showed severe tricuspid 
insufficiency. The FVW-PV normalized when the right ventricle function was restored 
after laser therapy,8,  10 proving the concept that the pulmonary atresia at time of 
TTTS diagnosis is a functional. Only one prenatal pulmonary atresia case resulted 
in postnatal severe valvular pulmonary stenosis. In this case, right ventricular 
dysfunction persisted with ventricular dilatation and severe tricuspid insufficiency. 
The TTTS was diagnosed early in the second trimester, when semilunar valve 
formation is not fully completed.26 Overall, we found that early TTTS was associated 
with postnatal RVOTO, confirming the findings in a retrospective cohort previously 
published by our group.5 We hypothesize that the fetal heart at early gestation might 
be more vulnerable to hemodynamic changes and endothelial damage, caused by 
hypertension and accelerated by circulating vasoactive mediators, which eventually 
leads to valve dysplasia.
Anatomical changes at valve level result in an elevated peak systolic velocity across 
the PV, and this series shows that these FVWs are less favorable to be reversible 
after cardiac function is restored. Thus, elevated peak systolic velocity across the 
pulmonary valve carries a higher risk of postnatal valve pathology, with the need of 
intervention, compared with isolated pulmonary insufficiency or functional pulmonary 
atresia. Counselling and ultrasonographic follow-up could be adjusted to this finding.
It has been suggested previously that recipients in higher Quintero stages of TTTS 
are more likely to develop postnatal RVOTO.10, 11 In this prospective cohort, prenatal 
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RVOTO at TTTS diagnosis seem to occur more frequently in the advanced stages of 
TTTS, but postnatal RVOTO was equally found in all Quintero stages. We hypothesize 
that severe cardiac dysfunction with subsequent prenatal RVOTO is more frequently 
present in advanced stages of TTTS, while pulmonary valve dysplasia might occur 
equally in all stages. Development to postnatal RVOTO is possibly facilitated by 
a longer period of volume overload, shear stress, and transfusion of vasoactive 
mediators. This vascular programming effect in the setting of intertwin differences, 
altered by different treatment strategies of TTTS, has been reported previously.27-29 In 
our cohort, this is illustrated by three cases with expectant management in Quintero 1 
that showed pulmonary stenosis. TTTS improved completely, but pulmonary stenosis 
was progressive in two cases, with the need of balloon valvuloplasty in the third 
week of life in one case. For detection of postnatal RVOTO in recipients, we propose 
extended fetal echocardiographic follow-up 1 to 2 months after laser therapy or TTTS 
diagnosis and routine postnatal echocardiographic follow-up at the corrected age of 
1 months.
It should be noted that the sample size is still limited, although relatively large compared 
with other studies on this subject. In addition, routine postnatal echocardiographic 
assessment could not be performed in all neonates, mainly because patients 
preferred delivery at their referral hospitals. This means that the prevalence of mild 
RVOTO could be underestimated.
Conclusion
Recipients with severe postnatal RVOTO all show abnormal FVW-PV at the time of 
TTTS diagnosis. Recipients with a pattern of elevated peak systolic velocities across 
the PV seem to be more likely to develop postnatal RVOTO than patterns showing 
isolated pulmonary insufficiency or functional pulmonary atresia. Early gestational 
age and duration of hemodynamic adaptation to TTTS might be a stronger predictor 
than Quintero stage for postnatal RVOTO. Importantly, mild RVOTO can develop 
weeks after laser therapy or even in the neonatal period, and routine prenatal and 
postnatal cardiac evaluation is recommended in all surviving recipients of TTTS.
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CHAPTER VII
Measurement of cardiac function by 
cardiac time intervals, applicability in 






To detect early cardiac deterioration, a simple and stable tool is needed. Measurement 
of time intervals in a simple 4-chamber view using color-coded tissue Doppler imaging 
is a relatively new approach to assess fetal cardiac function. The aim of this study was 
to evaluate the applicability of this modality and to construct reference ranges for 
cardiac time intervals.
Methods  
We performed a prospective longitudinal cohort study in healthy fetuses. We used 
linear mixed models to construct age-adjusted reference ranges for shortening time 
(St) and lengthening time (Lt) in three cardiac regions: global heart and right and 
left ventricular wall. St and Lt were expressed as percentage of the cardiac cycle. 
Feasibility and intra- and interobserver variabilities were evaluated. We applied the 
technique to twin–twin transfusion syndrome (TTTS) recipients before laser therapy 
to test the diagnostic performance.
Results  
A total of 251 recordings were obtained from 54 healthy singletons. St decreased and 
Lt increased with gestational age in all regions. We found a high feasibility (99.6%) 
and excellent intra-/interobserver variability for St (0.96/0.94) and Lt (0.99/0.96) of 
the global heart. Left and right ventricle performance parameters were good. In TTTS 
recipients, St was prolonged (p < 0.01) and Lt was shortened (p < 0.01) in all regions 
and the feasibility was excellent (96.6%).
Conclusion  
The assessment of fetal cardiac function by measurement of cardiac time intervals is 
technically feasible with good reproducibility, even in difficult scanning circumstances 
such as TTTS. It is possible to discriminate between healthy and compromised fetuses 
with this technique.




Assessment of fetal cardiac function gained much interest in the last decade. New 
ultrasound technologies like speckle tracking and tissue Doppler seem promising. 
Conventional Doppler is increasingly used to assess cardiac function in the so-
called modified myocardial performance index (MPI). However, this is mainly used 
in tertiary care centers in research settings. Implementation in general practice is 
hampered by the need for extensive training to ensure acceptable performance and 
reproducibility.1, 2 Normal ranges of MPI vary widely, and despite a clear agreement 
about the landmarks of the time periods, interobserver agreement is often 
disappointing.3-6 A simple, stable quantitative measurement of cardiac function, 
which is suitable for daily assessment, is not yet available. There is, however, a need 
to predict early functional deterioration of fetuses that are at risk of cardiac failure.7
Tissue Doppler imaging (TDI) has been used since the early 1990s in adult 
echocardiography,8 but is a relatively new technique in fetal echocardiography. 
Pulsed-wave TDI technique is similar to pulsed-wave Doppler, but focuses on lower 
frequency shifts, which enables measurement of lower velocities like myocardial 
wall motion. Color-coded recordings are easy to obtain in a simple four-chamber 
view. In color-coded tissue Doppler imaging (cTDI), the representation of myocardial 
velocities is superimposed on gray-scale two-dimensional or M-mode images, to 
indicate the direction and velocity of myocardial motion.9
In adults, cTDI is used as prognostic tool in heart failure and differentiation 
between constrictive pericarditis and restrictive cardiomyopathy.10-12 In fetal 
echocardiography, cTDI was first described for the assessment of myocardial 
velocities by Paladini et al.,13 in pregnancies complicated by intrauterine growth 
restriction or gestational diabetes.14- 18 cTDI does not differentiate between active 
motion and passive motion; thus, fetal or maternal movements may cause artefacts. 
Velocity measurements are, furthermore, influenced by angle of insonation and the 
size of the used region-of-interest (ROI).19, 20 The applicability of the use of velocities 
in fetuses is, therefore, limited. In contrast, time intervals are independent of the 
angle of insonation and ROI size, making the use of time intervals a promising new 
approach for the assessment of fetal cardiac function. 15, 19
In cTDI images, change in the direction of the myocardial wall motion is visible as 
a nadir in the curve. We hypothesize that these nadirs can be used as transition 
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markers to indicate the moment from shortening to lengthening of the myocardium. 
This might be an easy and reproducible technique to measure cardiac time intervals 
to express fetal cardiac function.
The aim of our study was to evaluate the applicability of cTDI in terms of feasibility, 
intra- and interobserver variability. We created reference curves of the shortening 
time (St) and lengthening time (Lt) of the myocardial wall, in specific areas in the 
fetal heart and the whole heart, visualized in the four-chamber view. In addition, we 
evaluated St and Lt in twin–twin transfusion syndrome (TTTS) recipients, who typically 
show compromised cardiac function, to investigate the ability to discriminate between 
normal and abnormal cardiac function.
Methods
Uncomplicated singleton pregnancies were recruited in a primary care center and 
at our fertility department between November 2014 and December 2016. The 
pregnancies were dated by crown to rump (CRL) measurement in the first trimester 
or date of conception in IVF pregnancies. Conditions that possibly influence 
fetal cardiac function were excluded, including maternal diabetes, pregnancy 
induced hypertension, pre-eclampsia, systemic lupus erythematosus, fetal heart 
malformations, and birth weight below the 5th percentile.
Color-coded Doppler clips were acquired using a Toshiba Aplio 500 with a PVT-
674BT 6  MHz transducer in early second trimester and a PVT-375BT 3.5  MHz 
transducer in late second and third trimester. A measurement software package 
(Toshiba Medical Systems Corporation) was used for analysis. Ultrasonographic 
examinations were repeatedly performed between a gestational age (GA) of 16 
and 36 with a monthly interval. Fetal biometry and standard 2D echocardiography 
were performed in each examination. In the absence of fetal movements, at least 
two color-coded tissue Doppler recordings, containing 5 or more cardiac cycles, 
were stored in an apical or basal four-chamber view. Settings were optimized with 
the heart covering approximately 60% of the image, to obtain the highest frame 
rates per second.20 The examinations were limited to a 15 min slot per fetus for the 
complete examination.
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Time intervals in color-coded tissue Doppler recordings
In images derived from cTDI, the change of direction in myocardial movement results 
in nadirs in the curve. Shortening time (St) was defined as the duration of myocardial 
motion when the ventricular wall shortens, and is expressed as percentage of the 
cardiac cycle. Lengthening time (Lt) was defined as the duration of myocardial motion 
when the ventricular wall extends, and expressed as percentage of the cardiac cycle. 
St and Lt are not the same as systole and diastole, which are defined by opening and 
closure of the semilunar valves and by not myocardial motion. Time intervals between 
St and Lt were noted as inter St-Lt and inter Lt-St times.
As demonstrated in Figure 1, the nadirs that delineate St and Lt were defined as 
the ones with the smallest angle towards the direction of shortening, respectively 
lengthening movement. The cardiac cycle with the most appropriate delineation of 
the time intervals was selected and stored separately for analysis. Three regions of 
interest (ROI) were examined in each clip. A large ROI was used to evaluate global 
heart function. The large ROI was placed around the total heart depicted as four-
chamber view, covering at least both ventricles. Two smaller ROI’s were used to 
evaluate specific areas in the fetal heart (Figure 1): at the base of the right ventricular 
wall (RV), just beneath the tricuspid valve, and at the base of the left ventricular 
wall, just beneath the mitral valve (LV). The smaller ROI’s were placed just below the 
attachment of the AV valves at the free ventricular wall at the end of systole with the 
AV valves closed, to measure the base of the ventricle, as shown in Figure 1. The size 
of this ROI covered the width of myocardial wall, but did not involve the AV valve.
▲Figure 1. Schematic illustration of the cardiac cycle using cTDI, placement of regions of interest 
(ROI) and demarcations of lengthening time (Lt) and shortening time (St) in the derived image
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To investigate the ability to express abnormal cardiac function of this measurement, 
we performed cTDI measurements on all recipients with TTTS referred to our 
department between January 2015 and December 2016. We used the last 
ultrasound examination before laser therapy. Recipients may demonstrate cardiac 
dysfunction at time of TTTS diagnosis.21 We stored 2 color-coded tissue Doppler 
recordings, containing 5 or more cardiac cycles for analysis of the St and Lt. 
Because TTTS occurs mainly between 14 to 28  weeks, we compared recipients 
with healthy singletons within this gestational age period. Thus, the TTTS recipients 
were matched at the level of gestational age. All examinations were performed and 
analyzed by one experienced operator (S.E.). For intraobserver agreement, 30 clips 
containing one raw cardiac cycle of the singleton group were stored, and analyzed 
three times with a time interval of 3 months. For interobserver agreement, a second 
operator (M.G.) performed three analyses on the same 30 cardiac cycles. The mean 
of the three analyses of both operators was compared for interobserver agreement. 
Within-fetus variability was defined as agreement in three different cardiac cycles 
in different clips in one examination, and analyzed by the same operator (S.E.). 
The study was approved by the medical ethical committee of the Leiden University 
Medical Center and all women signed informed consent.
Statistical analysis
Statistical analysis was performed with IBM SPSS 20.0 statistical package (Chicago, 
IL, USA). Feasibility was defined as the percentage of measurements, which could be 
performed successfully. A measurement was noted as successful if the signal was 
clear enough to recognize all 4 nadirs. A measurement was unsuccessful in case 
of absent nadirs, or multiple nadirs in which the demarcation nadir could not be 
recognized. Baseline characteristics between healthy singletons and recipients were 
compared with the t test and Chi-square test.
Intra- and interobserver agreement and within-fetus variability were quantified by the 
intraclass correlation coefficient. Because of the longitudinal character of this study, 
we used linear mixed models in which we included a random intercept per individual 
to account for the correlated measurements within each fetus. For each outcome 
variable, we evaluated whether the gestational age trend increased or decreased 
over time, using a mixed model with a fixed linear age effect. We used this same 
model to construct reference intervals for healthy singletons. To compare means of 
TTTS recipients and healthy singletons, we constructed a second mixed model for 
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each outcome including gestational age, group (healthy singleton or TTTS recipient) 
and the interaction between age and group as fixed effects. From this model, we 
estimated the mean difference between the groups at the mean observed gestational 
age.
Results
The baseline characteristics of the healthy singletons and the TTTS recipients are 
depicted in Table 1. Sixty-one singletons were eligible for inclusion, but seven cases 
were excluded from analysis, because gestational diabetes or intrauterine growth 
restriction developed during gestation.
A total of 251 examinations were performed in 54 healthy singletons. Performance 
parameters are summarized in Table 2. Feasibility in the global heart and the right 
ventricular wall was excellent (99.6%/93.6%), and good in the left ventricular wall 
(78.1%). The mean global shortening time was 45.8% of the cardiac cycle at 16 weeks 
of gestation, and decreased significantly to 42.4% at 36  weeks of gestation, while 
mean global lengthening time was 42.8% of the cardiac cycle at 16 weeks of gestation, 
and increases to 44.6% at 36  weeks of gestation. Normal reference curves are 
constructed and are shown in Figure 2. The inter St-Lt and inter Lt-St time frames 
were noted and analysed, as shown in Table 2. While inter St-Lt appears to be stable 
during gestation, inter Lt-St increases in all ROI’s.
Intraobserver agreement within a cardiac cycle was good for the global heart, the right 
and the left ventricular wall (St 0.98/0.94/0.91 and Lt 0.99/0.94/0.89). Interobserver 
agreement was excellent for the global heart (St 0.94 and Lt 0.96), and reasonable in 
the right ventricular wall (St 0.76 and Lt 0.72) and left ventricular wall (St 0.82 and Lt 
0.74). The intraclass correlation coefficient for within-fetus variability varied between 
0.17 and 0.61 in all ROIs, reflecting high variability of the heart cycle within the same 
fetus. Mean frame rate per second (fps) was 98, and standard deviation was 35 fps. 
Lower frame rates were associated with advanced gestational age.
Baseline characteristics for TTTS recipients are comparable with healthy singletons 
(Table 1). In 86 recordings of recipients at time of TTTS diagnosis, feasibility was 96.6% 
for global ROI, 94.2% for RV, and 70.0% for LV. Lengthening time was significantly 




Table 1. Demographic characteristics and pregnancy outcome of singletons and recipients
Singletons
% or mean (+- SD)
N=54
Recipients
% or mean (+- SD)
N=86
p-value
Caucasian 93.2 97.0 0.17
Maternal body mass index (kg/m2) 23.3 ± 3.1 24.6 ± 4.6 0.05
Gestational age at delivery (weeks) 39.6 ± 1.4 31.5 ± 5.1 
Birth weight (grams) 3500 ± 496 1985 ± 630
5-min Apgar score 9 ± 1 8 ±1












Mean frame rate per second 
in 2nd trimester 
124 ± 22 122 ± 30 0.91












Global   
St 45.8 (3.3) 42.4 (3.3) <0.01 99.6 0.98 0.94 0.60
Lt 42.8 (4.5) 44.6 (4.5) 0.049 0.99 0.96 0.56
Inter St-Lt 9.5 (3.8) 10.2 (3.8) 0.42 0.99 0.95 0.27
Inter Lt-St 3.1 (2.2) 5.1 (2.2) <0.01 0.90 0.97 0.46
RV
St 46.1(3.7) 42.1(3.7) <0.01 93.6 0.94 0.76 0.47
Lt 44.7 (4.3) 46.8 (4.3) 0.02 0.94 0.72 0.38
Inter St-Lt 5.8 (3.0) 6.0 (3.0) 0.88 0.88 0.77 0.20
Inter Lt-St 3.7 (2.3) 5.5 (2.3) <0.01 0.88 0.78 0.17
LV 
St 47.0 (4.1) 42.6 (4.1) <0.01 78.1 0.91 0.82 0.29
Lt 39.8 (5.0) 44.5 (5.0) <0.01 0.89 0.74 0.61
Inter St-Lt 3.9 (2.6) 5.6 (2.6) 0.01 0.92 0.60 0.29
Inter Lt-St 4.0 (2.6) 5.6 (2.6) 0.01 0.86 0.74 0.19
CTDI, Color Tissue Doppler Imaging; SD, standard deviation; ROI, region of interest; St, Shortening time; 
Lt, Lengthening time; RV, right ventricular wall; LV, left ventricular wall; Intra-CC, intraclass correlation 
coefficient for intraobserver agreement; inter-CC, intraclass correlation coefficient for interobserver 
agreement
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▲Figure 2. Reference charts for Lt and St in healthy singletons, in different regions of interest 
in the fetal heart from 16 to 36 weeks of gestation
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Table  3. Mean (SD) St and Lt for singletons versus recipients at time of TTTS diagnosis, in 









St 48.3 (4.7) 44.9 (2.7) 3.0 (1.9-4.1) <0.01
Lt 37.6 (5.3) 43.4(4.5) 5.6 (4.1-7.0) <0.01
Inter St-Lt 9.7 (4.7) 8.1 (4.0) 1.7 (0.4-2.8) 0.01
Inter Lt-St 4.3 (2.5) 3.7 (2.3) 0.8 (0.0-1.5) 0.04
RV
St 49.0 (7.5) 45.2 (2.7) 3.1 (1.2-5.0) <0.01
Lt 37.2 (7.1) 45.6 (4.2) 8.1 (6.3-9.9) <0.01
Inter St-Lt 8.3 (2.5) 5.3 (3.1) 2.8 (1.7-4.0) <0.01
Inter Lt-St 4.4 (3.0) 3.7 (2.3) 0.4 (-1.2-0.4) 0.30
LV 
St 48.9 (7.5) 45.8 (3.6) 3.1 (1.8-4.4) <0.01
Lt 34.8(5.7) 41.2 (4.9) 6.1 (4.3-7.9) <0.01
Inter St-Lt 10.4 (3.7) 4.3 (2.5) 6.0 (4.9-7.1) <0.01
Inter Lt-St 5.8 (4.1) 4.3 (2.5) 1.5 (0.3-2.6) 0.01
ROI, region of interest; St, Shortening time; Lt, Lengthening time; RV, right ventricular wall; LV, left 
ventricular wall; *the difference is tested based on the mean difference between recipients and 
singletons at 21 weeks using the linear mixed model; CI, confidence interval
 




▲Figure  3. Scatterplots for recipients at time of TTTS diagnosis versus singletons reference 




In this study, we introduce a new approach to assess fetal cardiac function through 
the measurement of time intervals of the myocardial wall motion, in a simple four-
chamber view using cTDI. Lengthening time and shortening time of the fetal heart show 
a slight increase, respectively, decrease with advancing gestation. Feasibility and intra- 
and interobserver agreement were shown to be excellent in the global heart ROI. The 
high feasibility (96.6%) in difficult circumstances like TTTS, with polyhydramnios and 
abundant fetal movements of the recipient, indicates that this approach is simple and 
robust. Lt was shortened and St prolonged in TTTS recipients compared to healthy 
singletons, reflecting the discriminative ability of this new parameter.
Currently, the myocardial performance index (MPI) is the most used method to assess 
fetal cardiac function. MPI is considered a consistent cardiac marker which becomes 
altered in early stages of chronic hypoxia or cardiac overload.22 MPI implementation 
in routine assessment has several limitations. First, MPI is a pulsed-wave Doppler-
derived index of isovolumetric time intervals (IRT/ICT) and ejection time (ET) and 
ventricular inflow and outflow are ideally measured in the same cardiac cycle. For 
left MPI measurement, a combined flow velocity waveform recording of mitral valve 
and aorta outflow can be obtained in the same sample volume, but these recordings 
require considerable expertise of the operator in image acquisition and correct 
recording of the Doppler tracing. The anatomy of the tricuspid valve and pulmonary 
artery, however, precludes recording of both valves within the same Doppler 
sample gate in the right ventricle, which is the dominant ventricle in fetal circulation. 
Therefore, right MPI can only be calculated from two separate recordings, which 
affects feasibility and reproducibility. As a result, normal ranges of both left and 
right MPI vary widely and interobserver agreement is disappointing.3-6 Another 
difficulty in MPI measurements is the caliper placement in the Doppler waveforms 
to calculate the time intervals. This seems to be resolved with the development 
of automated MPI systems which removes the subjectivity of manual caliper 
placement, but authors acknowledge that ultrasound image acquisition remains a 
potential source of variability, even for highly trained operators.23, 24 Contrary, the 
cTDI recordings described in this study are easy to obtain because only a recording 
of the four-chamber view is needed. The four-chamber view is easy to acquire and 
is part of every routine obstetric ultrasound examination. The placement of the ROI 
is simple and fast, which makes this technique applicable in daily obstetrical care in 
the future.
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The measurement of cardiac time intervals in cTDI is a relatively new approach in fetal 
echocardiography.15 Willruth et al.19 concluded that time intervals can be analyzed 
with a high accuracy, irrespective of which ROI size is used. They described IRT, 
ICT, and ET retrieved by cTDI, comparable to these parameters in Doppler-derived 
MPI. Interobserver agreement in this study was low, probably because the closure 
and the opening of the cardiac valves are not easy to recognize in the signal. In our 
approach of the analysis of the same signal, cardiac time intervals are marked by 
myocardial wall motion and not by the movement of the blood. Instead of ET, which 
represents blood volume shift and is marked by cardiac valve clicks, we propose to 
evaluate St, which reflects the time the myocardium actually contracts. By definition, 
St will be longer than ET, because the myocardium first starts to contract, and with 
increased intraventricular pressure, the semilunar valve opens and the ejection of 
blood starts. Lt is prolonged in the same manner (Figure 1). Consequently, the inter 
St–Lt and inter Lt–St are shorter than the isovolumetric time intervals. As shown 
in Table 2, the inter-shortening–lengthening time as well as the inter-lengthening–
shortening time show a large standard deviation in all ROIs which we attribute to 
measurement error caused by the current frame rates. Therefore, the value of inter 
St–Lt, respectively, and Lt–St in individual measurements is limited.
However, this approach of the analysis of cTDI signal results in an excellent feasibility 
and intra- and interobserver agreement for global heart function, which is better 
than current used techniques to assess fetal cardiac function. This is explained by 
the simplicity of the large ROI placement and the easy recognition of the nadirs 
in the curve. We observed that wall motion in the smaller ROIs is less consistent 
and several smaller nadirs may be visible, which results in a larger interobserver 
variability. We observed that the LV shows lower feasibility scores compared to 
the RV. The previous studies show lower volume shifting and less ventricular wall 
displacement in the left ventricle compared to the right ventricle in fetal life,15, 25-26 
which might explain the nadirs to be less clear, which results in lower feasibility 
scores and reproducibility.
In contrast to intra- and interobserver agreement, within-fetus variability in 
our study was high in all areas of the fetal heart. We hypothesize that the high 
within-fetus variability can be attributed to beat-to-beat (BTB) variability, which is 
a physiological phenomenon mediated by the autonomic nervous system. This 
hypothesis is consistent with a recently published study by Maheshwari et al.,27 
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who showed that MPI time intervals have a BTB variability which is comparable with 
the fetal heart rate variability. BTB variability is well established in various Doppler 
flow measurements, and the occurrence of physiological changes as possible 
contributors to measurement variation is mentioned before in studies assessing 
repeatability.28, 29
Recipients in TTTS show abnormal cardiac function, and it is earlier suggested 
that cardiac profiling can be an aid in early management of TTTS.30,  31 Our study 
shows deviations in mean cardiac time intervals with a shortened Lt, prolonged St, 
and prolonged inter St-Lt in recipients, which confirms findings of abnormal MPI 
and prolonged isovolumetric contraction time.32,  33 The within-fetus variability in 
normal fetuses, together with the overlap of the results in TTTS recipients with the 
normal values, makes distinction in TTTS difficult. Care should be taken, and further 
research is needed to determine the diagnostic accuracy of cTDI. The feasibility 
rates we found in the TTTS recipients are, however, exceptional high compared to 
the current techniques, as it is known that the retrieval of Doppler recordings in 
TTTS is difficult because of the polyhydramnios and the abundant fetal movements 
of the recipient. A feasibility rate of 96.6% proves that this method is simple and 
fast. Future studies are planned by our group to elucidate the possible role of cTDI 
in monitoring monochorionic twins.
To investigate the ability to discriminate between normal and abnormal cardiac 
function, recipient twins were matched for gestational age to healthy singletons. 
The lack of a control group of uncomplicated twins is a limitation of our study. It is, 
however, well accepted that reference charts of healthy singletons are compared 
to complicated monochorionic twins. In the previous studies in the field of fetal 
cardiology, speckle tracking-derived fetal cardiac function and modified MPI 
measurements in recipient twins were compared to normal singleton fetuses.24, 34, 35 
Uncomplicated (monochorionic) twins are generally not used as a control group, 
since twin pregnancies cannot be considered normal because of their complexity 
and high risk of complications.




In conclusion, the proposed technique presents a promising new approach to 
assess fetal cardiac function. Recordings are easy to obtain and feasibility and inter- 
and intraobserver agreement are excellent for global heart function, even in difficult 
scanning circumstances as TTTS recipients. Therefore, this technique is potentially 
useful in daily practice, because it can be applied in only a four-chamber view. 
Furthermore, this approach seems promising in the detection of abnormal heart 
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The unique placental angioarchitecture in monochorionic twin pregnancies carries 
a high risk for adverse pregnancy outcome. Disproportionate distribution of 
placental mass may result in selective intrauterine growth restriction (sIUGR), and 
unbalanced intertwin transfusion across the intertwin anastomoses causes twin to 
twin transfusion syndrome (TTTS). These conditions are known to result in unique 
changes in the hemodynamic balance in these fetuses, compared to singletons. 
Important complications which contribute significantly to the unfavorable outcome 
of the pregnancies are fetal demise and right ventricular outflow tract obstruction 
(RVOTO). 
The prediction of fetal demise and the development of postnatal RVOTO is still 
challenging, but would be helpful in counseling, the planning of follow-up visits and the 
development of innovative treatment options of TTTS and sIUGR. The general aim of 
the studies presented in this thesis was to gain more knowledge about hemodynamic 
adaptation of the fetal heart in complicated monochorionic twin pregnancies, in order 
to understand the pathways of abnormal cardiac development and fetal demise 
under these circumstances, which eventually could lead to better future care.
Part one – fetal demise 
Twin-to-twin transfusion syndrome
A seemingly straightforward laser surgery ending in fetal demise of one or both twins 
is a frustrating matter for both parents and fetal surgeons. Earlier reports showed 
that abnormal flows in the ductus venosus and umbilical artery in TTTS are associated 
with this complication of laser therapy and our data confirm these findings (chapter 
2 and 3). Besides that, the data in our retrospective cohort show that the presence 
of an AA anastomosis for donors, and the absence of a compensating recipient-to-
donor anastomosis for the recipient, increase the risk for unexpected fetal demise 
after laser therapy (chapter 3). Our study is the first attempt to investigate the type of 
anastomoses in relation to fetal demise in TTTS. 
The question raises how anastomoses influence mortality rates in TTTS. It has been 
hypothesized before that the combination of type and size of anastomoses determine 




coagulation of placental anastomoses causes acute volume changes in the intertwin 
circulation, which has an immediate impact on cardiac preload in the recipient and 
afterload in the donor, which demands an instant cardiac adaptation of in both 
fetusses. A suggested way to minimize this acute change is reducing the immediate 
hemodynamic challenge by sequential selective laser therapy, whereby anastomoses 
are coagulated in a specific order, by starting with the coagulation of the largest 
donor-to-recipient arteriovenous anastomoses followed by the smaller ones and after 
these the occlusion of the recipient-to-donor arteriovenous anastomoses. Finally, if 
present, the arterioarterial and the venovenous anastomoses will be coagulated. It is 
hypothesized that intraoperative correction of the hypoperfusion of the donor and 
hyperperfusion of the recipient is achieved in the time interval between the sites of 
coagulation and will reduce mortality. A meta-analysis of three small non-randomized 
studies suggests an improved fetal survival from 88% to 92% using this technique, but 
a large randomised trial is lacking.1-4 On one hand, the data in our study support the 
approach of sequential laser therapy, because it could be hypothesized that occlusion 
of a AA-anastomosis early in surgery magnifies the hemodynamic forces in the other 
anastomoses and for that, increase the risk for fetal demise. On the other hand, it is 
questionable if sudden hemodynamic changes during laser therapy can be avoided at 
a sufficient magnitude by a different order of occlusion because all anastomoses are 
usually coagulated within a short time period. 
Another suggested way to improve fetal survival after laser therapy is medical 
stabilization of fetal circulation before laser coagulation, to decrease the vulnerability to 
acute preload and afterload changes when the intertwin anastomoses are coagulated. 
A matched case control study in 141 cases explored transplacental treatment with 
nifedipine 24-48 hours prior to laser therapy and showed an increased survival of 
the recipient twin, but the donor survival showed no difference.5 Nifedipine is a type 
2 calcium channel blocker of which the primarily effect is vasodilatation and is widely 
used for treatment of hypertension in pregnant woman. It crosses the placenta and 
achieves serum levels in the fetus.6 The hypothesis is that the vasodilatation decreases 
the hemodynamic forces (increased cardiac preload) on forehand and lowers the 
impact of sudden hemodynamic changes during laser coagulation. In this way, the 
pre-laser impact of the absence of a compensating recipient-to-donor anastomosis 
for the recipient is less prominent, which makes the acute hemodynamic change less 
challenging during and after intervention. For donors, the potential effect of pre-laser 
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vasodilatation is debated and could have the opposite effect because of the decrease 
in preload in an already hypovolemic fetus. The above-mentioned study did not show 
that, and we hypothesize a possible protective effect in cases of the presences of 
an AA anastomosis. If TTTS develops in the presence of an AA anastomosis it may 
act as a strong unidirectional shunt.7 Vasodilatation may reduce the flow across this 
shunt before the laser surgery. In this way it may lower the risk for the donor, as our 
study found an increased risk for demises in donors in case of the presence of an 
AA anastomosis in TTTS. A multi-center randomised controlled trial is the next step 
to confirm the case control study5 and explore out hypothesis that it might even be 
beneficial for donors. 
Alternatively to calcium channel blockers, positive inotropic medical treatment could 
be considered to optimize fetal myocardial contraction around laser therapy, for 
example with digoxin. Pre-laser the hypovolemic donor will benefit from increased 
cardiac contractility. The recipient faces sudden decreased preload after laser surgery 
and those that show cardiomyopathy might benefit from increased contractile force 
achieved by medical treatment. The long loading time of digoxine, however, makes 
this experiment difficult to explore. 
Proximate cord insertion
A second topic addressed in this thesis is the presence of intermittent absent 
and reversed end-diastolic flow in the umbilical artery (iAREDF) in uncomplicated 
monochorionic pregnancies with proximate cord insertion (PCI) (chapter 4). We are 
the first to describe the pathophysiological mechanism behind this phenomenon and 
the possible association with fetal deterioration. Our data show that iAREDF occurs in 
64% of cases with PCI and is related to the diameter of the AA-anastomosis. Our data 
suggest that iAREDF in PCI pregnancies is a possible risk factor for fetal deterioration 
and demise. No other reports studying the relationship of iAREDF and PCI are 
available. PCI is, however, seen in 53% of monochorionic monoamniotic pregnancies,8 
and pathophysiology of fetal demise in PCI in monoamniotic and diamniotic twin 
pregnancies might be partly comparable. In monoamniotic pregnancies, unexpected 
fetal demise is a well-known risk and is mostly attributed to cord entanglement. 
Cord entanglement is, however, not always found in these cases after birth. It was 
hypothesized by Lewi9 that other causes, such as acute exsanguination across large 




an explanation for unexpected demise as well. The findings in our study in cases with 
proximate cord insertions with large anastomoses might be explained in a similar 
way. 
It is currently unknown whether fetal outcome in PCI-diamniotic pregnancies can be 
improved by altered management. Our study raises the question if, and (if so) at which 
gestational age intensified fetal monitoring should be pursued in PCI pregnancies. 
Firstly, the findings in this study suggest that awareness of the combination of iAREDF 
and PCI could be relevant in daily clinical practice. PCI is currently not considered as 
a risk factor for sudden demise and is therefore not investigated and documented 
in (uncomplicated) MCDA pregnancies. The still existing unexpected fetal death in 
MCDA pregnancies could possibly be explained by the presence of PCI. We therefore 
suggest to record PCI in all MCDA pregnancies. Secondly, this study suggests that 
increased fetal surveillance might be helpful in known PCI cases. The effect of 
intensified ultrasound examination, whether or not in combination with intensified 
fetal monitoring using fetal cardiotocography, is still unclear. Hypothetically these 
monitoring interventions might detect fetal  distress timely, and therewith prevent 
further deterioration. On the other hand, the only available treatment is delivery, 
which will occur preterm in most of these cases. Whether or not the benefit of preterm 
delivery outweighs the possible complications of prematurity is unknown. Besides 
that, intensive monitoring will increase fear in patients or might lead to long hospital 
admissions which brings additional costs. Better understanding of the magnitude 
of this clinical finding should be achieved by a multicenter registry study, followed 
eventually by a randomized controlled trial that compares different approaches of 
fetal monitoring and intervention options in PCI cases.
Part two – cardiac compromise
Part two of this thesis determines the incidence of postnatal right ventricular outflow 
tract obstruction (RVOTO) to be 6.7% in recipient twins, of which 2.9% need balloon 
valvuloplasty in the neonatal period (chapter 6). Our large cohort enabled us to 
describe the spectrum of prenatal RVOTO and following development to postnatal 
RVOTO, which can be an aid in future care and counseling. 
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Prediction and follow-up of RVOTO in complicated mono-
chorionic pregnancies
Firstly, we constructed a prediction model for development of postnatal RVOTO in 
TTTS recipients. As predictors we found pericardial effusion, abnormal flow in ductus 
venosus and early gestational age at TTTS onset (chapter 5). Although it is important to 
realize that mild RVOTO can develop weeks after laser therapy or even in de neonatal 
period, neonates with severe postnatal RVOTO (defined as the need for neonatal 
surgical intervention) all showed prenatal RVOTO at TTTS diagnosis (chapter 6).  
Pericardial effusion and abnormal flow in the ductus venosus are well known 
alterations in severe TTTS cases (Quintero stage III and IV). Both are reflections of 
cardiac compromise in TTTS. Pericardial effusion is included in the criteria for hydrops, 
and an earlier report showed that up to one third of hydropic recipients develop 
postnatal cardiac abnormalities including RVOTO.10 Laser therapy often improves 
cardiac function, and is recommended in severe TTTS.11-13  
The association of postnatal RVOTO with an early gestational age at TTTS diagnosis is 
a new and important finding. We propose that this is related to the fact that early in 
the second trimester semilunar valve maturation is not complete.14 Therefore these 
cardiac valves might be more susceptible to hemodynamic imbalances leading to 
RVOTO. In these circumstances endothelial damage, caused by hypertension and 
accelerated by circulating vasoactive mediators, eventually leads to valve dysplasia 
and pulmonary stenosis. 
A longer period of exposure to the hemodynamic challenges in TTTS could facilitate 
the development of valve dysplasia and could increase the risk for postnatal RVOTO, 
especially in early gestational age. This hypothesis is supported by the new finding that 
postnatal RVOTO occurs equally in all Quintero stages and was also found in cases 
with Quintero stage I with expectant management (chapter 6). This finding raises the 
question if abnormal flows in the right ventricular outflow tract could be a reason to 
initiate laser treatment to prevent postnatal RVOTO in prolonged Q1 TTTS. However, 
the current risk of complications for laser surgery, such as fetal demise of donor 
(17%) or recipient (13%) (chapter 2), immature birth (4,5%) (chapter 3), premature 
preterm rupture of membranes (40%)15,16 and following preterm birth15 are still much 
higher than the risk for severe postnatal RVOTO. Besides that, treatment of postnatal 




iatrogenic preterm birth by laser intervention even more unfavorable in these cases.17 
For these reasons, we do not recommend laser treatment in these cases solely to 
prevent postnatal RVOTO.
Awareness of development of postnatal RVOTO is, however, recommended. As 
mentioned above, neonates with postnatal RVOTO might need balloon valvuloplasty in 
the newborn period and will benefit by a delivery in a center with pediatric cardiology 
services to ensure timely cardiac intervention. Laser treatment is worldwide centered 
in specialized centers for fetal therapy, and after treatment, patients are often 
referred back to their local hospitals with sometimes large travel distances to centers 
with specialized cardiac neonatal care. 
We recommend that fetuses with a combination of pericardial effusion, early gestational 
age at TTTS diagnosis, abnormal flow in DV and even expectant management in Q1-
TTTS, should receive echocardiographic follow-up in a specialized center to estimate 
the risk for postnatal RVOTO. In the spectrum of antenatal RVOTO, we found that 
cases with elevated peak systolic velocity across the pulmonary valve have a higher 
risk for developing postnatal RVOTO than cases with isolated pulmonary insufficiency 
or functional pulmonary atresia (chapter 6). This might be explained by the hypothesis 
that pulmonary insufficiency and atresia is mostly a functional expression of cardiac 
dysfunction due to the volume overload in TTTS-recipients, which restores after 
successful laser treatment. On the opposite, elevated peak systolic velocity across 
the valve occurs when dysplasia results in valvular stenosis. In that way, elevated 
peak systolic flow reflects anatomical changes of the valve, which is less likely to fully 
recover after laser treatment. 
These findings could be an aid in clinical decision making concerning TTTS treatment, 
as well as counseling and the planning of follow-up visits of patients with high risk 
for development of postnatal RVOTO. Firstly, functional pulmonary atresia is a very 
impressive ultrasonographic finding which might lead to the suspicion of long-term 
cardiac disease or the end-stage of cardiac failure. Consequently this might steer 
clinical decision making towards the consideration of selective cord coagulation of 
the RVOTO twin, instead of the usual laser treatment. Our study shows that this 
ultrasonographic finding is often reversible after successful laser therapy, and for 




Secondly, elevated peak systolic velocity across the PV is a more subtle ultrasonographic 
finding, but carries a higher risk for development of postnatal RVOTO. For that, cases 
with elevate peak systolic velocity across the PV should be advised to deliver in a 
center with pediatric cardiology services to ensure proper neonatal care and the 
availability of cardiac intervention in severe cases. Cases with isolated pulmonary 
insufficiency or functional pulmonary atresia eventually could deliver in their local 
centers, if improvement of cardiac function is confirmed with prenatal follow-up 
scans. 
An additional new finding is that RVOTO may develop in TTTS donors and the large 
twins of sIUGR-cases (chapter 5). As described above, donors face an acute cardiac 
challenge after laser therapy as well. When intertwin anastomoses are coagulated, 
a transition from pre-laser hypovolemia to sudden increased afterload has to be 
endured. Although pre-laser recipients face an increased preload and post-laser 
donors an increased afterload, the ultrasonographic (transient) cardiac findings are 
comparable. Earlier reports describe an abnormal ductus venosus, tricuspid valve 
insufficiency and even hydrops in up to 25% of donors after lasercoagulation.18-20 In 
addition to this, the donors in our study did not show any signs of cardiac dysfunction 
pre-laser, and developed RVOTO after a transient period of hydrops directly following 
laser treatment (chapter 5). We postulate that a period of acute shear stress after 
laser treatment could lead to endothelial damage and eventually valvular dysplasia in 
these circumstances, and in that way increase the risk for postnatal RVOT, comparable 
to recipients. 
The large twin in sIUGR-cases do not face such event of sudden hemodynamic 
challenge and exact pathophysiology of development of RVOTO remains unknown. 
We speculate that large arterioarterial anastomoses, present in 98% of sIUGR 
cases, combined with a large placental mass in the early stages of pregnancy may 
cause disturbances in intracardiac flow, which might cause cardiac dysfunction. The 
hypertrophic cardiomyopathy-like changes that have been found in the larger twin 
of sIUGR cases with large arterioarterial anastomoses support this hypothesis.21 
Again the pathophysiology might find its origin in the endothelial damage caused 
by disturbed flows, which causes stenosis in the pulmonary valve. A longer duration 
of abnormal flow exposure might facilitate the development of postnatal RVOTO, as 
described above in Q1 cases TTTS with expectant management. Since there is no 




to a low number of cases factors associated with development of postnatal RVOTO 
could not be investigated. We recommend awareness of cardiac changes such as 
pericardial effusion and RVOTO in the larger twin in case of severe sIUGR, especially 
when sIUGR was present from early second trimester. 
Color-coded tissue Doppler imaging (cTDI) in fetal echo-
cardiography
Innovative cardiac function measurements such a cTDI are increasingly used and 
proven valuable in the prediction of outcome in adult cardiac disease. In fetal 
echocardiography, a simple quantitative measurement of cardiac function that 
predicts cardiac compromise in high-risk fetuses, is needed. In current practice, MPI 
is considered a consistent cardiac marker to detect early chronic hypoxia or cardiac 
overload.22 Pulsed-wave Doppler derived MPI recordings are, however, difficult to 
obtain and right MPI can only be calculated from two separate recordings which 
affects feasibility and reproducibility. This makes it less suitable for usage in daily 
practice.
In chapter 7 we investigate cTDi in fetal echocardiography, and introduce a new 
modality to assess fetal cardiac function by the measurement of cardiac time 
intervals using this technique. Measurement of shortening time and lengthening 
time of the myocardial wall are applied in a four-chamber view. The recordings are 
therefor easy to obtain and potentially useful for daily practice. In a study in healthy 
singletons and TTTS recipients we demonstrated that this modality is technically 
feasible with good reproducibility, even in difficult scanning circumstances such 
as TTTS. It discriminates between healthy and compromised fetuses. One other 
study confirms that measurement of time intervals using cTDI can be analyzed with 
a high accuracy.23 However, since our study is the first to evaluate shortening and 
lengthening time intervals with this modality, larger studies are needed to confirm 
our findings. Even more important, the predictive value of this new approach to 
assess fetal cardiac function should be investigated in different study populations 
of fetuses in challenging circumstances. Although future use of this new modality 
seems promising, implementation will be dependent on a wider range of pregnancy 
complications and the development of automatic analysis of the retrieved signal.
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Future perspective and conclusion
The studies presented in this thesis show that the hemodynamic challenges of the 
placental angioarchitecture in monochorionic twin pregnancies play a crucial role in 
the mortality rate and cardiac outcome of these twins. Although diagnostic tools and 
fetal interventions have improved the outcome of these pregnancies tremendously in 
the past decades, there is room for improvement. 
Future perspective
To increase survival rates in TTTS, future research should focus on the possible benefit 
of individualized treatment for these fetuses, such as specific sequential laser therapy 
whether or not in combination with presurgical medical stabilization of hemodynamic 
forces. Ideally, the number and size of intertwin anastomoses should be visualized 
before surgery with innovative techniques such as 3D-mapping, in order to detect 
high-risk placental angioarchitecture. In this way, not only the introduction site for 
the fetoscope can be optimized, but the sequential laser order can be determined 
on beforehand. This will shorten the operation time which reduces rate of rupture 
of membranes. Besides that, different types of medication could be considered 
to achieve medical stabilization around laser therapy. The challenge herein is that 
medication that might be beneficial to the recipient might not be beneficial to the 
donor and the other way around. Additionally, hemodynamic forces change directly 
after laser therapy for both fetuses, which will result in different needs for each fetus. 
Conclusion
The overall conclusion of the studies presented in this thesis is that individualized 
care could further improve fetal outcome in monochorionic pregnancies. New 
insights into risk factors for fetal deterioration, such as the presence of PCI or the 
presence/absence of certain anastomosis in TTTS, identifies relatively small groups of 
vulnerable fetuses. This gives the opportunity to develop a more individual approach 
in follow-up or treatment in these cases, which might lower the risk for fetal demise 
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Monochorionic twin pregnancies carry a high risk for adverse pregnancy outcome. 
The unique placenta angioarchitecture with the shared blood circulation might cause 
specific complications such as twin tot twin transfusion syndrome (TTTS) or selective 
intrauterine growth restriction (sIUGR). The hemodynamic challenges in these 
complications require specific adaptation of the fetal heart. Subsequently, a higher 
risk for fetal demise and acquired cardiac abnormalities is present in these cases. 
The general aim of the studies presented in this thesis was to gain more knowledge 
about hemodynamic adaptation of the fetal heart in complicated monochorionic 
twin pregnancies, in order to understand more of the pathways of abnormal cardiac 
development and fetal demise under these circumstances, which eventually could 
lead to better future care.
Part one - Fetal demise
In the first part of this thesis, we focused on the risk for fetal demise in complicated 
MCDA pregnancies. If left untreated, the perinatal mortality in TTTS is over 90%. 
Fetoscopic laser therapy of placental anastomoses significantly improves the overall 
survival rate to ≈ 70% and to > 85% for at least one surviving fetus.
Several studies have been performed in order to predict fetal demise after fetoscopic 
laser treatment for TTTS. In chapter 2 we performed a systematic review and meta-
analysis to compare pre-operative ultrasonographic parameters between fetuses 
with and without fetal demise after laser surgery. After assessment of study quality, 
a total of eighteen studies were included. Donors were at higher risk for fetal demise 
(23%) than recipients (17%). The risk for fetal demise was highest within 24 hours 
after laser therapy (52% and 42% of the total demises respectively), and the majority 
of fetal demise occurred within one week after laser therapy (74% and 88% of the 
total demises respectively).  Mortality rates declined from 29% for donors and 21% 
for recipients in the early years of fetoscopic laser coagulation, to 19% and 13% in the 
last decade. 
For both donor and recipient, preoperative absent/reversed end diastolic flow 
in the umbilical artery and an absent or reversed a-wave in the ductus venosus 
were associated with fetal demise. These flows are classified as Quintero stage 3. 
Additionally, increased velocity in the median cerebral artery (MCA) is associated with 
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fetal demise in recipients as well. The mechanisms leading to abnormal flow velocity 
waveforms are different in donors and recipients. For donors, we speculated that the 
abnormal flows reflect both placental insufficiency and fetal hypotension secondary 
to the TTTS. For recipients, the mechanism leading to abnormal flows is different. It is 
suggested that poor myocardial contractility as a result of hypervolemia and cardiac 
overload causes abnormal flows in the umbilical artery and ductus venosus. The 
increased velocity in the MCA might be the reflection of the hypervolemic status of 
the recipient. Another suggested explanation for the MCA flows in recipients is that 
decreased fetal oxygenation due to placental interstitial edema causes this elevated 
velocity in the MCA. In conclusion,  abnormal Dopplers reflect an unstable circulation 
which increase the risk for fetal demise for both donors and recipients.
Data on myocardial function were only available in seven studies. Meta-analysis 
could only be performed for atrioventricular regurgitation, and turned out to be not 
associated with a higher risk for fetal demise. An association between preoperative 
MPI and fetal demise of the donor was not found. For recipients data were conflicting: 
2 studies found a possible correlation between elevated MPI and recipient demise, 3 
did not. We concluded that the utility of preoperative parameters that reflect cardiac 
function in predicting IUFD remains unclear.
In chapter 3 we investigated possible predictors of single fetal demise after laser 
treatment in our national referral center for TTTS in a retrospective cohort of 273 
pregnancies. Overall fetal survival was 84%. Single fetal demise occurred in 11% 
of donors and 10% of recipients, of which 67% occurred within 7 days after laser 
therapy. For donors, absent/reversed end-diastolic flow in the umbilical artery was the 
strongest predictor, followed by the presence of an AA anastomoses and discordance 
in estimated fetal weight. In recipients, independent predictors were absent/reversed 
a-wave in the ductus venosus and the absence of recipient-to-donor arteriovenous 
anastomoses. In previous literature, the association between these abnormal blood 
flows and fetal demise is described several times before (see chapter 2). The 
classification of these FVWs are incorporated in the current staging system for TTTS 
(Quintero stage III). 
The association of specific types of anastomosis and fetal demise is not studied before. 
We speculate that the type and size of anastomoses that are present, determines the 
degree of hemodynamic change during and directly after laser therapy. Although AA 
anastomoses are thought to equalize blood flow between fetuses and have a protective 
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effect against TTTS, we hypothesized that if this anastomosis is unable to prevent 
TTTS, it functions as a strong AV anastomosis. For that, it has a strong influence on 
the acute peri-and postoperative hemodynamic changes, which eventually increase 
the risk for fetal demise. However, currently there is no method to investigate the flow 
across the anastomoses. We recommend that future studies should focus on the role 
of different types and sizes of the placental anastomoses.
In general, monochorionic twin pregnancies carry a risk of fetal demise of 1%, even in 
the absence of complications such as TTTS or sIUGR. Still, the placental architecture 
is thought to play a role in these unexpected demises. In chapter 4, we studied the 
possible risk for fetal demise in case of otherwise uncomplicated MCDA pregnancies 
with proximate cord insertion (PCI). MCDA pregnancies with PCI often have a large 
AA anastomosis between the cord insertions. Large AA anastomosis are known to 
attribute to unstable haemodynamics between the two fetuses in MCDA twins with 
sIUGR, with the risk of sudden fetal demise of the smaller twin.  In pregnancies with 
PCI, the risk for fetal deterioration is unknown. In our study we studied 11 pregnancies 
with PCI and 33 uncomplicated MCDA pregnancies without PCI. We confirmed that 
the diameter of the AA anastomosis was significantly larger in the PCI group. In the 
PCI group, 7 cases showed intermittent absent and reversed end diastolic flow in 
the umbilical artery, compared to none in the control group. In 4 cases, iAREDF 
was transient and pregnancy outcome was favorable. In 3 cases fetal deterioration 
occurred, followed by fetal demise in 2 cases and iatrogenic early preterm birth in the 
third case. We hypothesize that the vascular resistance in the AA diameter is lower in 
case of PCI, because of the larger diameter and shorter distance compared to cases 
without PCI. This could magnify a sudden exsanguination between fetuses and may 
increase the risk for fetal demise. Although strong conclusions cannot be made based 
on this small cohort, we recommend awareness for iAREDF in the presence of PCI. 
A large observational multicenter study is needed to evaluate the prevalence and 
pregnancy outcome of iAREDF in PCI, before specific management in these cases can 
be suggested.
Part two – Cardiac compromise
In part two, we investigated the cardiac consequences of complicated MCDA 
pregnancies. In the last decades, prenatal right ventricular outflow tract obstruction 
(RVOTO) is increasingly recognized in TTTS cases. Preoperative RVOTO often may 
disappear after laser treatment, however, in some cases it might worsen during 
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pregnancy and require surgery or catheter intervention in the newborn period or in 
early infancy. We focused on the understanding of the process leading to postnatal 
RVOTO, and investigated possible associated factors of the development of RVOTO.
No prediction model for development of postnatal RVOTO is available in current 
literature. In chapter 5 we describe a retrospective observational cohort study of all 
monochorionic twins with postnatal diagnosis of RVOTO in our center (2004-2015). 
We aimed to evaluate pregnancy characteristics in order to determine factors that 
are associated with the development of postnatal RVOTO. We found a total of 485 
pregnancies treated for TTTS, and postnatal RVOTO was diagnosed in 3% of recipients. 
We encountered postnatal RVOTO in one donor as well. Associated factors for RVOTO 
were early gestational age at TTTS diagnosis, absent or reversed a-wave in the ductus 
venosus and the presence of pericardial effusion. TTTS in these cases occurred at a 
mean of 17+3 weeks of gestation, compared to 20+3 weeks of gestation in controls. 
This finding suggests an increased vulnerability to hemodynamic imbalances in the 
young developing fetal heart.  Absent or reversed a-wave in the ductus venosus and 
the presence of pericardial effusion are both a reflection of compromised cardiac 
function in the late stages of TTTS. We constructed a prediction model for postnatal 
RVOTO, incorporating these three variables and suggest to perform accurate follow-
up in TTTS cases in case of presence of these variables.
Beside TTTS survivors, three larger twins in pregnancies complicated with selective 
intrauterine growth restriction developed postnatal RVOTO. In these cases the onset 
of RVOTO was detectable early in second trimester, confirming the finding in TTTS 
survivors that the young fetal heart is more vulnerable for development of postnatal 
RVOTO. In sIUGR, large AA anastomoses are typically present. We speculated that a 
large AA anastomosis, mainly in early stages of pregnancy, may cause disturbances 
in intracardiac flows leading to postnatal RVOTO. The prevalence of postnatal RVOTO 
in the large twin in sIUGR is a new finding, and awareness of cardiac changes in early 
and severe cases of sIUGR is recommended. 
To assess the development and spectrum of RVOTO in recipients, we performed a 
prospective longitudinal study in 124 consecutive TTTS cases (2015-2017). The results 
are described in chapter 6. Three subgroups of prenatal RVOTO were identified. In 
the first group forward flow across the pulmonary valve was absent, with exclusive 
reverse direction of flow in the ductus arteriosus. This was classified as pulmonary 
atresia, which is often a functional pulmonary atresia. The second group showed 
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elevated peak systolic velocity of the pulmonary valve classified as pulmonary stenosis, 
and the third group showed isolated pulmonary insufficiency. Prenatal RVOTO was 
diagnosed in 12.9% of recipients at TTTS diagnosis. In another 5.6% of cases, prenatal 
RVOTO appeared only after laser therapy.
Postnatal RVOTO was found in 6.7% of surviving recipients, of which 70% showed 
prenatal RVOTO before laser therapy and 30% only after laser therapy. Notably, all 
recipients with severe postnatal RVOTO showed prenatal RVOTO at the time of TTTS 
diagnosis. The incidence of postnatal RVOTO found in this study is slightly higher than 
in prior large cohort studies, which can be explained by the systematic longitudinal 
follow-up of all recipients, which allowed us to detect mild and late-onset cases. 
We evaluated the three subgroups of prenatal RVOTO. Cases with elevated peak 
systolic velocities  across the pulmonary valve were more frequently associated with 
postnatal RVOTO compared to cases with prenatal ‘pulmonary atresia’. We suggested 
that elevated peak systolic velocity is a result of valve dysplasia, which is an anatomical 
change of the valve and may be less favorable to be reversible after laser therapy. 
In contrast, pulmonary atresia is more often the result of impaired right ventricle 
function, which is likely to normalize when cardiac function is restored after laser 
therapy. Lastly, none of the cases with isolated pulmonary insufficiency developed 
postnatal RVOTO. We suggested that this may be a relatively mild functional finding in 
TTTS which is presumably reversible after laser therapy.
In this study, postnatal RVOTO was associated with early manifestation of TTTS, which 
confirms the finding in chapter 5. Although prenatal RVOTO was more frequently 
observed in advanced Quintero stages, postnatal RVOTO was equally found in all 
Quintero stages. We hypothesize that severe cardiac dysfunction leading to prenatal 
RVOTO is more frequently present in advanced stages of TTTS, while pulmonary 
valve dysplasia might occur equally in all Quintero stages. We suggested that valve 
dysplasia is facilitated by an early gestational age combined with a longer period of 
volume overload, shear stress and inter-twin transfusion of vasoactive mediators. 
The latter is illustrated by three cases in our cohort with expectant management in 
Quintero 1 that showed pulmonary stenosis. While TTTS improved completely in all 
cases, pulmonary stenosis was progressive in two cases with the need of balloon 
valvuloplasty in the neonatal period in one case.  
To detect early cardiac compromise that might lead to RVOTO or fetal demise in TTTS, 
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a simple, stable quantitative measurement of cardiac function is needed. Currently, 
the myocardial performance index (MPI) is the most used method to assess fetal 
cardiac function. MPI is the ratio of isovolumetric cardiac time intervals to ejection 
cardiac time interval, and represents myocardial function. MPI recordings are, 
however, difficult to obtain and require considerable expertise of the operator, which 
hampers usage in daily practice. In chapter 7 we introduce a new modality to detect 
fetal cardiac dysfunction. We measured the shortening time (St) and lengthening time 
(Lt) of the myocardial wall in three cardiac regions, using color-coded tissue Doppler 
imaging in the four chamber view of the fetal heart. We performed a prospective 
longitudinal cohort study in 54 healthy fetuses, performing a total of 251 recordings. 
Firstly, we aimed to evaluate the applicability of this modality. We found a high 
feasibility (99.6%) and excellent intra-/interobserver variability for St and Lt of the 
global heart. Left and right ventricle test performance parameters were good. 
Therefore we considered this  technique is easy to obtain in only an four chamber 
view with good reproducibility, and so potentially useful in daily practice in the future.
Secondly, we constructed age-adjusted reference ranges for the time intervals. 
St decreased and Lt increased with gestational age in all regions. We applied 
this technique to recipients in TTTS before laser therapy, to test the diagnostic 
performance in fetuses with cardiac compromise. The feasibility was excellent (96.6%). 
St was prolonged and Lt was shortened in all regions. These altered time intervals are 
comparable to the altered time intervals in abnormal MPI in recipients.
Based on the findings in this study, we concluded that the assessment of fetal cardiac 
function by measurement of cardiac time intervals is technically feasible with good 
reproducibility, even in difficult scanning circumstances such as TTTS. It is possible 
to discriminate between healthy and compromised fetuses with this technique. 
Further studies should, however, be performed to analyze the usage of this modality 
in treatment or prediction of fetal outcome in pathological pregnancies.
This thesis is finalized by chapter 8, which provides a general discussion and 
interpretation of the chapters described in this thesis. Secondly, a scope for future 
research in this research field is suggested. 
In conclusion, this thesis provides studies that could be an aid in fetal clinical 
management and neonatal follow-up of twins in monochorionic pregnancies, and 




Monochoriale tweelingzwangerschappen hebben een verhoogd risico op een 
ongunstige zwangerschapsuitkomst. De unieke samenstelling van de placentaire 
anastomosen en de (ongelijke) verdeling van het placentavolume over beide foetus 
kan complicaties zoals Tweeling Transfusie Syndroom (TTS) en selectieve intra-
uteriene groeirestrictie (sIUGR) veroorzaken. De veranderde hemodynamica in deze 
complicaties vraagt een groot aanpassingsvermogen van het foetale hart, waardoor 
er een hoger risico bestaat op intra-uterien overlijden en het ontwikkelen van foetale 
hartafwijkingen.
Het doel van de studies beschreven in dit proefschrift was om meer kennis 
te verkrijgen over de hemodynamische aanpassingen van het foetale hart in 
gecompliceerde monochoriale diamniotische (MCDA) tweelingzwangerschappen. Op 
deze manier hopen we meer inzicht te verkrijgen over de verschillende manieren 
waarop hartafwijkingen ontstaan en bij welke foetussen een verhoogde kans is op 
intra-uteriene sterfte, waardoor de zorg voor MCDA zwangerschappen in de toekomst 
verbeterd kan worden. 
Deel I – intra-uteriene vruchtdood
In het eerste deel van dit proefschrift ligt de focus op het onderzoeken van het risico 
op intra-uteriene vruchtdood (IUVD) in MCDA zwangerschappen. In onbehandelde 
TTS is de perinatale sterfte meer dan 90%. Door foetale lasertherapie, waarbij de 
placentaire anastomosen tussen beide foetus worden dicht gelaserd, verbetert de 
totale foetale overleving naar ongeveer 70% en de overleving van in elk geval één van 
beide foetus naar >85%. 
Er zijn meerdere studies verricht naar de voorspellende factoren van IUVD na 
lasertherapie. In hoofdstuk 2 beschreven wij een systematische review en meta-
analyse waarin wij preoperatieve echografische parameters in foetussen met en 
zonder IUVD vergelijken. Na beoordeling van de kwaliteit van de studies werden 18 
studies geïncludeerd. Donoren bleken een hoger risico te hebben op IUVD (23%) dan 
recipiënten (17%). Het risico op IUVD was het hoogst in de 24 uur na de lasertherapie 
(52% respectievelijk 42%) en de meerderheid vond plaats binnen een week na de 
lasertherapie (74% respectievelijk 88%). De foetale sterfte daalde van 29% voor 
donoren en 21% voor recipiënten in de beginjaren van deze behandeling, naar 19% 
respectievelijk 13% in het afgelopen decennium.
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Voor zowel de donor als de recipiënt zijn een preoperatief afwezige of reversed eind 
diastolische flow over de arteria umbilicalis en een abnormale a-wave in de ductus 
venosus geassocieerd met IUVD. Deze afwijkende flows zijn geïncorporeerd in het 
huidige stadiëring systeem, en geclassificeerd als Quintero stadium 3. Daarnaast is 
een verhoogde snelheid in de arteria cerebri media (ACM) ook geassocieerd met 
IUVD in de recipiënt. De mechanismen die leiden tot abnormale flows verschillen in 
donoren in vergelijking tot recipiënten. Wij speculeerden dat de abnormale flows in 
donoren de placentaire insufficiëntie en hypotensie reflecteren, die op hun beurt het 
gevolg zijn van TTS. In recipiënten is dit mechanisme anders en wordt er gedacht dat 
een verminderde contractiliteit van het myocard, als gevolg van de hypovolemie en 
cardiale overbelasting in TTS, resulteert in abnormale flows in de arteria umbilicalis 
en ductus venosus. De verhoogde snelheid in de ACM zou een reflectie kunnen zijn 
van de hypervolemische status van de recipiënt. Een andere hypothese zou kunnen 
zijn dat de verminderde foetale oxygenatie, ontstaan door interstitieel oedeem 
van de placenta, deze verhoogde snelheid veroorzaakt. Concluderend reflecteren 
abnormale Doppler flows een instabiele circulatie die het risico op IUVD voor zowel 
donoren als recipiënten verhoogd. 
Data over myocardfunctie waren slechts in zeven studies beschikbaar. Meta-analyse 
kon alleen verricht worden over atrioventriculaire insufficiëntie en dat was niet 
geassocieerd met een hoger risico op IUVD. Ook werd er geen relatie gevonden 
tussen myocardial performance index (MPI) en IUVD van de donor. Voor recipiënten 
was de data niet eenduidig: 2 studies beschrijven een mogelijke correlatie tussen een 
verhoogd MPI en IUVD, 3 studies vonden deze correlatie niet. Wij concludeerden dat 
de bruikbaarheid van preoperatieve hartfunctie parameters in de voorspelling van 
IUVD in TTS vooralsnog onduidelijk is.
In hoofdstuk 3 beschreven wij een retrospectief cohortonderzoek van 273 
zwangerschappen, welke werd verricht in ons nationale verwijscentrum voor foetale 
therapie. Wij onderzochten mogelijke voorspellende factoren voor IUVD van één van 
beide foetus. De totale foetale overleving in deze studie was 84%. IUVD vond plaats in 
11% van de donoren en 10% van de recipiënten, waarvan 67% in de eerste 7 dagen 
na lasertherapie. In de groep donoren was afwezige of reversed eind diastolische flow 
in de arteria umbilicalis de sterkste voorspellende factor voor IUVD, gevolgd door de 
aanwezigheid van een arterio-arteriële anastomose (AA-anastomose) en het verschil 
in geschat foetaal gewicht van beide foetussen. In de groep recipiënten waren 
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onafhankelijke voorspellende factoren voor IUVD een abnormale a-wave in de ductus 
venosus en de afwezigheid van een arterioveneuze anastomose van recipiënt naar 
donor. De associatie tussen abnormale flows en IUVD is meerdere keren beschreven 
in eerdere literatuur (zie hoofdstuk 2). 
De associatie tussen IUVD en de aan- of afwezigheid van specifieke anastomosen is 
niet eerder in de literatuur beschreven. Het is aannemelijk dat het type en de grootte 
van de aanwezige anastomosen op de placenta de mate van hemodynamische 
verandering tijdens en direct na de lasertherapie bepalen. Van AA-anastomosen 
wordt gedacht dat ze de bloedstromen tussen de foetussen stabiliseren en op 
die manier beschermen tegen de ontwikkeling van TTS. Wij hypothetiseren dat, 
als een AA-anastomose toch voorkomt in TTS, het zich gedraagt als een sterke 
arterioveneuze anastomose. Daardoor heeft het een sterke invloed op de acute peri- 
en postoperatieve hemodynamische schommelingen, wat het risico op IUVD kan 
verhogen. Op dit moment is er echter nog geen valide methode ontwikkeld om deze 
hypothese te onderzoeken. Toekomstig onderzoek zou zich meer kunnen richten op 
de rol van  verschillende types en de grootte van de placentaire anastomosen in 
relatie tot IUVD.
Monochoriale tweelingzwangerschappen hebben een verhoogd risico van 1% op 
IUVD in afwezigheid van TTS of sIUGR. De unieke placentaire angioarchitectuur 
speelt waarschijnlijk een rol in deze onverwachte IUVD’s maar de pathofysiologie 
is onbekend. In hoofdstuk 4 hebben we het mogelijke risico op onverwachte 
vruchtdood onderzocht in monochoriale tweelingzwangerschappen waarbij de 
navelstrenginserties dicht naast elkaar op de placenta liggen, zogenoemd ‘proximate 
cord insertion’ (PCI). In monochoriale tweeling-zwangerschappen met PCI is bijna altijd 
een grote AA-anastomose aanwezig tussen de navelstrenginserties. Het is bekend dat 
grote AA-anastomosen bijdragen aan een instabiele hemodynamica tussen foetussen 
in zwangerschappen gecompliceerd met sIUGR, waardoor het risico op plotseling 
overlijden van de kleinste foetus is verhoogd. In zwangerschappen met PCI is het 
risico hierop niet bekend. In deze studie onderzochten we 11 PCI zwangerschappen 
en 33 ongecompliceerde zwangerschappen zonder PCI. Zoals bekend uit voorgaand 
onderzoek bevestigden wij dat de diameter van de AA-anastomose groter was 
in de PCI groep dan de controle groep. In de PCI groep vonden wij in 7 gevallen 
een intermitterend afwezige en/of reversed eind diastolische flow over de arteria 
umbilicalis, in de controle groep werd dit niet gevonden. In 4 van deze gevallen was deze 
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afwijkende flow van voorbijgaande aard en verliep de zwangerschap ongecompliceerd. 
In 3 van de gevallen ging de foetale conditie achteruit bij de foetus waar de afwijkende 
flow werd geconstateerd. In 2 gevallen trad IUVD op, en in het 3e geval werd er een 
vroeggeboorte geïnduceerd om dit te voorkomen. Onze hypothese is dat, gezien de 
grotere diameter en de kortere afstand tussen de navelstrenginserties, de weerstand 
in de AA-anastomose lager is in PCI zwangerschappen in vergelijking tot de controle 
zwangerschappen. Dit zou eventuele plotselinge veranderingen van hemodynamica 
tussen de foetussen kunnen versterken en daardoor het risico op IUVD vergroten. 
Gezien dit een klein cohortonderzoek betreft kunnen er geen absolute conclusies 
getrokken worden, danwel specifieke management opties aanbevolen worden. Wel 
raden wij aan om in gevallen van PCI bewust te zijn van de ontwikkeling van afwijkende 
flows in de arteria umbilicalis. Wij adviseren een groot observationeel multicenter 
onderzoek om de prevalentie en zwangerschapsuitkomsten in PCI zwangerschappen 
te evalueren.  
Deel twee – cardiale aanpassing
In het tweede deel van dit proefschrift onderzochten we cardiale aanpassingen in 
gecompliceerde monochoriale tweelingzwangerschappen. In de laatste decennia 
wordt ‘right ventricular outflow tract obstruction’ (RVOTO) als gevolg van TTS steeds 
vaker prenataal ontdekt. Preoperatieve RVOTO kan voorbijgaan na lasertherapie, 
maar kan ook verergeren gedurende de zwangerschap waarbij dit operatief 
gecorrigeerd moet worden in de neonatale periode of in de jonge kindertijd. In dit 
proefschrift hebben we ons gericht op het leren begrijpen van de processen die 
leiden tot postnatale RVOTO, en we hebben mogelijk geassocieerde factoren voor 
het ontwikkelen hiervan onderzocht.
In de huidige literatuur was er geen predictiemodel beschikbaar voor de ontwikkeling 
van postnatale RVOTO. In hoofdstuk 5 beschreven wij een retrospectief cohort van 
alle monochoriale  tweelingzwangerschappen in ons centrum (2004-2015). Het doel 
was om de zwangerschapskarakteristieken van de casus met postnatale RVOTO te 
evalueren, om zo geassocieerde factoren voor de ontwikkeling hiervan te detecteren. 
In totaal vonden wij 485 zwangerschappen welke gecompliceerd waren met TTS, 
waarbij in 3% van de gevallen postnatale RVOTO werd gediagnosticeerd bij de recipiënt. 
Ook werd postnatale RVOTO vastgesteld in één van de donoren. Geassocieerde 
factoren met de ontwikkeling van RVOTO waren een vroege zwangerschapsduur bij 
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het ontstaan van TTS, een afwezige of reversed a-wave van de ductus venosus en de 
aanwezigheid van toegenomen pericardvocht. De gemiddelde zwangerschapsduur 
van vaststellen en behandeling van TTS in casus met RVOTO was 17 weken en 3 
dagen, ten opzichte van 20 weken en 3 dagen van de groep zonder ontwikkeling van 
postnatale RVOTO. Deze bevinding suggereert een grotere kwetsbaarheid van het 
jonge foetale hart voor hemodynamische instabiliteit. Afwezige of reversed a-wave in 
de ductus venosus en de aanwezigheid van toegenomen pericardvocht reflecteren 
beiden cardiale aanpassingen in de latere stadia van TTS. We construeerden een 
predictiemodel voor postnatale RVOTO met deze drie factoren en stellen een accurate 
follow-up voor in zwangerschappen met TTS waarbij deze variabelen aanwezig zijn. 
Naast de recipiënten en donoren in TTS, ontwikkelden ook drie foetus uit 
zwangerschappen gecompliceerd met sIUGR postnatale RVOTO. In deze drie casus 
werd de sIUGR en de RVOTO bij de grootste foetus al gezien vroeg in het tweede 
trimester. Dit bevestigt de hypothese dat het jonge foetale hart kwetsbaarder is en 
een hogere kans heeft op ontwikkeling van postnatale RVOTO bij hemodynamische 
veranderingen, in vergelijking tot het foetale hart later in de zwangerschap. 
In sIUGR zijn vaak grote AA-anastomosen aanwezig. Wij speculeerden dat deze grote 
AA-anastomosen verantwoordelijk zijn voor verstoorde flowpatronen intracardiaal, 
die met name vroeg in de zwangerschap kunnen leiden tot blijvende schade en 
ontwikkeling van postnatale RVOTO.  Het voorkomen van postnatale RVOTO in de 
grotere foetus van sIUGR zwangerschappen is een relatief nieuwe bevinding en 
oplettendheid op de ontwikkeling hiervan bij vroege en ernstige gevallen van sIUGR 
wordt aanbevolen in de dagelijkse kliniek.
Om het spectrum en de ontwikkeling van RVOTO in recipiënten te onderzoeken 
hebben wij een prospectief longitudinaal cohortonderzoek verricht in 124 
opeenvolgende TTS casus in onze kliniek (2015-2017). De resultaten staan beschreven 
in hoofdstuk 6. Wij onderscheidden drie subgroepen van prenataal RVOTO. De 
eerste groep werd geclassificeerd als pulmonale atresie, waarbij er geen voorwaartse 
stroming over de pulmonaal arterie meer te detecteren was en er over de ductus 
arteriosus omgekeerde flow te zien is. Dit is vaak een uiting van functionele atresie. In 
de tweede groep werd een verhoogde flow over de pulmonaalklep gevonden en werd 
geclassificeerd als pulmonaalstenose. In de derde groep was sprake van geïsoleerde 
pulmonaalklep insufficiëntie en deze werd als zodanig geclassificeerd. Prenataal 
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RVOTO werd in 12,9% van de recipiënten gediagnosticeerd op het moment van het 
vaststellen van TTS. In 5,6% van de recipiënten werd er juist prenataal RVOTO gezien 
na de lasertherapie terwijl dit daarvoor niet was vastgesteld. 
Postnatale RVOTO werd vastgesteld in 6,7% van de overlevende recipiënten, waarvan 
70% dit al voor de lasertherapie lieten zien en 30% alleen daarna. Alle recipiënten met 
ernstige postnatale RVOTO (waarvoor chirurgische behandeling noodzakelijk was) 
lieten de RVOTO al zien voor de lasertherapie. De incidentie van postnatale RVOTO 
in deze studie is iets hoger dan in voorgaande grote cohortonderzoeken bekend in 
de literatuur. Dit is te verklaren door het prospectieve karakter van deze studie met 
systematische longitudinale follow-up van alle recipiënten, waardoor wij enkele milde, 
late-onset gevallen konden vaststellen.
We evalueerden de drie subgroepen van prenatale RVOTO. De groep met prenatale 
pulmonaalstenose ontwikkelden vaker postnatale RVOTO dan de groep waarbij 
pulmonale atresie werd gezien. Onze hypothese is dat een verhoogde snelheid 
over de pulmonaalklep een uiting is van dysplasie van de pulmonaalklep. Dit is een 
anatomische verandering van de klep en daardoor is het minder waarschijnlijk dat deze 
reversibel is na lasertherapie. Pulmonale atresie is daarentegen vaak een resultaat 
van verminderde rechter ventrikel functie en dus een functionele verandering, die 
normaliseert als de hartfunctie hersteld is na lasertherapie. Als laatste vonden wij in de 
groep met geïsoleerde pulmonaalklep insufficiëntie geen kinderen met ontwikkeling 
van postnatale RVOTO. Dit suggereert dat dit een relatief milde bevinding is in TTS, 
welke reversibel is na behandeling. 
In deze studie werd postnatale RVOTO geassocieerd met ontwikkeling van TTS vroeg 
in de zwangerschap, wat de bevindingen in hoofdstuk 5 bevestigd. Hoewel prenatale 
RVOTO vaker voorkwam in de latere stadia van TTS (Quintero stadium 3 en 4), kwam 
postnatale RVOTO in alle  Quintero stadia gelijk voor. Onze hypothese is dat de ernstige 
cardiale dysfunctie in de latere stadia van TTS een functionele RVOTO veroorzaakt, 
terwijl pulmonaalklep dysplasie gelijk voorkomt in alle stadia. Dysplasie zou dan vaker 
optreden bij een vroege zwangerschapsduur en een langere blootstelling aan volume 
overbelasting, ‘shear stress’ en uitwisseling van vasoactieve mediatoren tussen de 
foetussen. Gezien dysplasie minder reversibel is na behandeling resulteert dit 
vaker in postnatale RVOTO. Dit wordt geïllustreerd door de drie casus in ons cohort 
waarbij expectatief management werd gevoerd in TTS Quintero stadium I en waarbij 
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pulmonaalstenose werd vastgesteld in de recipiënt. Terwijl de TTS in alle drie de casus 
verbeterde, was de pulmonaalstenose progressief in twee van de drie casus, waarbij 
in één van de casus chirurgische correctie middels ballon-valvuloplastiek nodig was 
in de neonatale periode.
Het is wenselijk om in een vroeg stadium foetaal cardiaal dysfunctioneren, dat op 
termijn zou kunnen leiden tot RVOTO of IUVD, te kunnen detecteren met een simpele 
stabiele en kwantitatieve meting. Op dit moment is de MPI de meest gebruikte methode 
om de foetale hartfunctie te beoordelen. MPI is de ratio tussen de isovolumetrische 
tijdsintervallen en de ejectietijd van het foetale hart en geeft de myocardfunctie weer. 
Het verkrijgen van de juiste echografische beelden voor het berekenen van de MPI 
is echter niet makkelijk en vereist een hoge mate van deskundigheid, waardoor de 
toepassing in de dagelijkse praktijk beperkt is. In hoofdstuk 7 introduceerden wij 
een nieuwe techniek om foetale hartfunctie te beoordelen. We bepaalden de tijd 
die het myocard nodig heeft om te verkorten, de ‘shortening time’ (St) en de tijd 
die het myocard nodig heeft om weer te ontspannen, de ‘lengthening time’ (Lt). We 
bepaalden deze tijdsintervallen in drie cardiale regio’s, namelijk het gehele hart, het 
linker- en het rechter ventrikel. De benodigde beelden worden verkregen met gebruik 
van color-coded tissue Doppler imaging en gemaakt in het vierkamerbeeld van het 
foetale hart. We verrichtten een prospectief longitudinaal cohortonderzoek in 54 
gezonde eenlingzwangerschappen met een totaal van 251 opnamen. 
Allereerst hebben wij de toepassing van deze techniek geëvalueerd. We vonden een 
hoge haalbaarheid (99,6%) en een excellente intra- en interobserver variabiliteit voor 
de St en Lt van het globale hart. De prestatie parameters voor het linker en rechter 
ventrikel waren goed. Op basis hiervan concludeerden we dat deze techniek goed 
reproduceerbaar is. Het vierkamerbeeld van het foetale hart is makkelijk te verkrijgen, 
deze techniek is dan ook potentieel bruikbaar in de dagelijkse kliniek.
Ten tweede hebben wij referentiewaarden gecreëerd voor deze tijdsintervallen. Lt 
nam toe St nam af met het toenemen van de zwangerschapsduur in alle regios. We 
pasten deze techniek toe op recipiënten om te testen of deze techniek verschillen 
zou meten in foetussen met een afwijkende hartfunctie. De uitvoerbaarheid was 
hoog (96,6%). St was verlengd en Lt was verkort in alle regio’s van het hart. Deze 
veranderingen in de tijdsintervallen zijn vergelijkbaar met de bekende veranderingen 
in MPI bij recipiënten.
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De bevindingen in deze studie laten zien dat het meten van de foetale hartfunctie met 
deze tijdsintervallen goed uitvoerbaar en goed reproduceerbaar is, zelfs in lastige 
echografische omstandigheden zoals TTS. Het is mogelijk om met deze techniek 
gezonde en cardiaal aangedane foetussen te onderscheiden. In de toekomst zullen 
meer studies verricht moeten worden om de bruikbaarheid van deze techniek te 
toetsen in de behandeling of voorspelling van foetale uitkomst in gecompliceerde 
zwangerschappen.
Dit proefschrift werd afgerond met hoofdstuk 8, waarin een algemene discussie en 
interpretatie van de uitkomsten van de studies werd beschreven. Daarnaast werd 
een suggestie gedaan voor toekomstig onderzoek in dit werkveld.
Concluderend kunnen de bevindingen beschreven in dit proefschrift bijdragen 
aan verbetering van klinische zorg, en foetale en neonatale follow-up van kinderen 
geboren uit monochoriale zwangerschappen. Daarnaast kunnen onze data gebruikt 
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AA-anastomosis  Arterio-Arterial anastomosis
A/REDF   Absent/Reversed End Diastolic Flow 
AVDR-anastomosis Arterio-Venous anastomosis from Donor to Recipiënt 
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IUFD   Intrauterine Fetal Demise
Lt   Lengthening time of the myocard
LUMC   Leiden University Medical Center
MCA   Middle Cerebral Artery
MCDA   Monochorionic-Diamniotic
MCMA   Monochorial-Monoamniotic
MI   Mitral Insufficiency
MPI   Myocardial Performance Index
NND   Neonatal Death
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PA   Pulmonary Atresia
PCI   Proximate Cord Insertion
PE   Pericardial Effusion
PI   Pulmonary Insufficiency
PPHN   Persistent Pulmonary Hypertension of the Neonate
PPROM   Preterm Prelabor Rupture of Membranes
PS   Pulmonary Stenosis
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ROI   Region of Interest
RVOTO   Right Ventricular Outflow Tract Obstruction
SFD   Single Fetal Demise
St   Shortening time of the myocard
sIUGR   selective Intra Uterine Growth Restriction
SLPCV   Selective Laser Photocoagulation of Communicating 
Vessels
TAPS    Twin Anemia Polycythemia Sequence
TI   Tricuspid Insufficiency
TTTS   Twin-Twin Transfusion Syndrome
UA   Umbilical Artery
UCC   Umbilical cord coagulation
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